2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
ObjectiveTo develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR).MethodsThis international initiative had four phases. (1) Evaluation of antinuclear antibody (ANA)...
Saved in:
| Published in | Annals of the rheumatic diseases Vol. 78; no. 9; pp. 1151 - 1159 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
BMJ Publishing Group Ltd and European League Against Rheumatism
01.09.2019
Elsevier Limited |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0003-4967 1468-2060 1468-2060 |
| DOI | 10.1136/annrheumdis-2018-214819 |
Cover
| Abstract | ObjectiveTo develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR).MethodsThis international initiative had four phases. (1) Evaluation of antinuclear antibody (ANA) as an entry criterion through systematic review and meta-regression of the literature and criteria generation through an international Delphi exercise, an early patient cohort and a patient survey. (2) Criteria reduction by Delphi and nominal group technique exercises. (3) Criteria definition and weighting based on criterion performance and on results of a multi-criteria decision analysis. (4) Refinement of weights and threshold scores in a new derivation cohort of 1001 subjects and validation compared with previous criteria in a new validation cohort of 1270 subjects.ResultsThe 2019 EULAR/ACR classification criteria for SLE include positive ANA at least once as obligatory entry criterion; followed by additive weighted criteria grouped in seven clinical (constitutional, haematological, neuropsychiatric, mucocutaneous, serosal, musculoskeletal, renal) and three immunological (antiphospholipid antibodies, complement proteins, SLE-specific antibodies) domains, and weighted from 2 to 10. Patients accumulating ≥10 points are classified. In the validation cohort, the new criteria had a sensitivity of 96.1% and specificity of 93.4%, compared with 82.8% sensitivity and 93.4% specificity of the ACR 1997 and 96.7% sensitivity and 83.7% specificity of the Systemic Lupus International Collaborating Clinics 2012 criteria.ConclusionThese new classification criteria were developed using rigorous methodology with multidisciplinary and international input, and have excellent sensitivity and specificity. Use of ANA entry criterion, hierarchically clustered and weighted criteria reflect current thinking about SLE and provide an improved foundation for SLE research. |
|---|---|
| AbstractList | To develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR).OBJECTIVETo develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR).This international initiative had four phases. (1) Evaluation of antinuclear antibody (ANA) as an entry criterion through systematic review and meta-regression of the literature and criteria generation through an international Delphi exercise, an early patient cohort and a patient survey. (2) Criteria reduction by Delphi and nominal group technique exercises. (3) Criteria definition and weighting based on criterion performance and on results of a multi-criteria decision analysis. (4) Refinement of weights and threshold scores in a new derivation cohort of 1001 subjects and validation compared with previous criteria in a new validation cohort of 1270 subjects.METHODSThis international initiative had four phases. (1) Evaluation of antinuclear antibody (ANA) as an entry criterion through systematic review and meta-regression of the literature and criteria generation through an international Delphi exercise, an early patient cohort and a patient survey. (2) Criteria reduction by Delphi and nominal group technique exercises. (3) Criteria definition and weighting based on criterion performance and on results of a multi-criteria decision analysis. (4) Refinement of weights and threshold scores in a new derivation cohort of 1001 subjects and validation compared with previous criteria in a new validation cohort of 1270 subjects.The 2019 EULAR/ACR classification criteria for SLE include positive ANA at least once as obligatory entry criterion; followed by additive weighted criteria grouped in seven clinical (constitutional, haematological, neuropsychiatric, mucocutaneous, serosal, musculoskeletal, renal) and three immunological (antiphospholipid antibodies, complement proteins, SLE-specific antibodies) domains, and weighted from 2 to 10. Patients accumulating ≥10 points are classified. In the validation cohort, the new criteria had a sensitivity of 96.1% and specificity of 93.4%, compared with 82.8% sensitivity and 93.4% specificity of the ACR 1997 and 96.7% sensitivity and 83.7% specificity of the Systemic Lupus International Collaborating Clinics 2012 criteria.RESULTSThe 2019 EULAR/ACR classification criteria for SLE include positive ANA at least once as obligatory entry criterion; followed by additive weighted criteria grouped in seven clinical (constitutional, haematological, neuropsychiatric, mucocutaneous, serosal, musculoskeletal, renal) and three immunological (antiphospholipid antibodies, complement proteins, SLE-specific antibodies) domains, and weighted from 2 to 10. Patients accumulating ≥10 points are classified. In the validation cohort, the new criteria had a sensitivity of 96.1% and specificity of 93.4%, compared with 82.8% sensitivity and 93.4% specificity of the ACR 1997 and 96.7% sensitivity and 83.7% specificity of the Systemic Lupus International Collaborating Clinics 2012 criteria.These new classification criteria were developed using rigorous methodology with multidisciplinary and international input, and have excellent sensitivity and specificity. Use of ANA entry criterion, hierarchically clustered and weighted criteria reflect current thinking about SLE and provide an improved foundation for SLE research.CONCLUSIONThese new classification criteria were developed using rigorous methodology with multidisciplinary and international input, and have excellent sensitivity and specificity. Use of ANA entry criterion, hierarchically clustered and weighted criteria reflect current thinking about SLE and provide an improved foundation for SLE research. ObjectiveTo develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR).MethodsThis international initiative had four phases. (1) Evaluation of antinuclear antibody (ANA) as an entry criterion through systematic review and meta-regression of the literature and criteria generation through an international Delphi exercise, an early patient cohort and a patient survey. (2) Criteria reduction by Delphi and nominal group technique exercises. (3) Criteria definition and weighting based on criterion performance and on results of a multi-criteria decision analysis. (4) Refinement of weights and threshold scores in a new derivation cohort of 1001 subjects and validation compared with previous criteria in a new validation cohort of 1270 subjects.ResultsThe 2019 EULAR/ACR classification criteria for SLE include positive ANA at least once as obligatory entry criterion; followed by additive weighted criteria grouped in seven clinical (constitutional, haematological, neuropsychiatric, mucocutaneous, serosal, musculoskeletal, renal) and three immunological (antiphospholipid antibodies, complement proteins, SLE-specific antibodies) domains, and weighted from 2 to 10. Patients accumulating ≥10 points are classified. In the validation cohort, the new criteria had a sensitivity of 96.1% and specificity of 93.4%, compared with 82.8% sensitivity and 93.4% specificity of the ACR 1997 and 96.7% sensitivity and 83.7% specificity of the Systemic Lupus International Collaborating Clinics 2012 criteria.ConclusionThese new classification criteria were developed using rigorous methodology with multidisciplinary and international input, and have excellent sensitivity and specificity. Use of ANA entry criterion, hierarchically clustered and weighted criteria reflect current thinking about SLE and provide an improved foundation for SLE research. To develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR). This international initiative had four phases. (1) Evaluation of antinuclear antibody (ANA) as an entry criterion through systematic review and meta-regression of the literature and criteria generation through an international Delphi exercise, an early patient cohort and a patient survey. (2) Criteria reduction by Delphi and nominal group technique exercises. (3) Criteria definition and weighting based on criterion performance and on results of a multi-criteria decision analysis. (4) Refinement of weights and threshold scores in a new derivation cohort of 1001 subjects and validation compared with previous criteria in a new validation cohort of 1270 subjects. The 2019 EULAR/ACR classification criteria for SLE include positive ANA at least once as obligatory entry criterion; followed by additive weighted criteria grouped in seven clinical (constitutional, haematological, neuropsychiatric, mucocutaneous, serosal, musculoskeletal, renal) and three immunological (antiphospholipid antibodies, complement proteins, SLE-specific antibodies) domains, and weighted from 2 to 10. Patients accumulating ≥10 points are classified. In the validation cohort, the new criteria had a sensitivity of 96.1% and specificity of 93.4%, compared with 82.8% sensitivity and 93.4% specificity of the ACR 1997 and 96.7% sensitivity and 83.7% specificity of the Systemic Lupus International Collaborating Clinics 2012 criteria. These new classification criteria were developed using rigorous methodology with multidisciplinary and international input, and have excellent sensitivity and specificity. Use of ANA entry criterion, hierarchically clustered and weighted criteria reflect current thinking about SLE and provide an improved foundation for SLE research. |
| Author | Jacobsen, Søren Bertsias, George Touma, Zahi Tani, Chiara Diamond, Betty Meroni, Pier Luigi Jayne, David Sanchez-Guerrero, Jorge Pego-Reigosa, José M Boumpas, Dimitrios T Smolen, Josef S Tedeschi, Sara K Schmajuk, Gabriela Johnson, Sindhu R Hahn, Bevra Aringer, Martin Wofsy, David Padjen, Ivan Yavuz, Sule Gladman, Dafna D Costenbader, Karen McCune, Joseph Halda-Kiss, Bernadett Wallace, Daniel J Hoyer, Bimba F Ruiz-Irastorza, Guillermo Massarotti, Elena Schneider, Matthias Anic, Branimir Doria, Andrea Naden, Ray Kamen, Diane L Costedoat-Chalumeau, Nathalie Brinks, Ralph Lerstrøm, Kirsten Mosca, Marta Ramsey-Goldman, Rosalind Khanna, Dinesh Rúa-Figueroa Fernández, Íñigo Hasni, Sarfaraz Vital, Edward M Cervera, Ricard Tanaka, Yoshiya Daikh, David Seror, Raphaèle Kumánovics, Gábor Stummvoll, Georg H Dörner, Thomas Graninger, Winfried Izmirly, Peter M Assan, Florence Czirják, László Mariette, Xavier Vasconcelos, Carlos Jung, Michelle Hiepe, Falk Clarke, Ann Elaine Urowitz, Murray Chan, Tak Mao Tektonidou, Maria G Leuchten, Nicolai Romero-Diaz, Juanit |
| Author_xml | – sequence: 1 givenname: Martin orcidid: 0000-0003-4471-8375 surname: Aringer fullname: Aringer, Martin email: martin.aringer@uniklinikum organization: Medicine III, University Medical Center and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany – sequence: 2 givenname: Karen surname: Costenbader fullname: Costenbader, Karen organization: Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA – sequence: 3 givenname: David surname: Daikh fullname: Daikh, David organization: University of California at San Francisco and VA Medical Center, San Francisco, California, USA – sequence: 4 givenname: Ralph surname: Brinks fullname: Brinks, Ralph organization: Policlinic and Hiller Research Unit for Rheumatology, Medical Faculty, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany – sequence: 5 givenname: Marta surname: Mosca fullname: Mosca, Marta organization: Department of Clinical and Experimental Medicine, Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa, Italy – sequence: 6 givenname: Rosalind surname: Ramsey-Goldman fullname: Ramsey-Goldman, Rosalind organization: Department of Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA – sequence: 7 givenname: Josef S surname: Smolen fullname: Smolen, Josef S organization: Department of Rheumatology, Medicine III, Medical University of Vienna, Vienna, Austria – sequence: 8 givenname: David surname: Wofsy fullname: Wofsy, David organization: Department of Medicine, Russell/Engleman Rheumatology Research Center, University of California at San Francisco, San Francisco, California, USA – sequence: 9 givenname: Dimitrios T surname: Boumpas fullname: Boumpas, Dimitrios T organization: Departments of Internal Medicine and Rheumatology, Clinical Immunology and Allergy, Medical School, University of Cyprus, Nicosia, Cyprus – sequence: 10 givenname: Diane L surname: Kamen fullname: Kamen, Diane L organization: Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA – sequence: 11 givenname: David surname: Jayne fullname: Jayne, David organization: Department of Medicine, University of Cambridge, Cambridge, UK – sequence: 12 givenname: Ricard surname: Cervera fullname: Cervera, Ricard organization: Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Barcelona, Spain – sequence: 13 givenname: Nathalie orcidid: 0000-0002-1555-9021 surname: Costedoat-Chalumeau fullname: Costedoat-Chalumeau, Nathalie organization: Medicine, Toronto Western Hospital, University Health Network, Mount Sinai Hospital, University of Toronto, Toronto Scleroderma Research Program, Toronto, Ontario, Canada – sequence: 14 givenname: Betty orcidid: 0000-0002-3250-3804 surname: Diamond fullname: Diamond, Betty organization: Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases, The Feinstein Institute for Medical Research, Manhasset, New York, USA – sequence: 15 givenname: Dafna D orcidid: 0000-0002-9074-0592 surname: Gladman fullname: Gladman, Dafna D organization: Division of Rheumatology, Department of Medicine, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada – sequence: 16 givenname: Bevra surname: Hahn fullname: Hahn, Bevra organization: Division of Rheumatology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA – sequence: 17 givenname: Falk surname: Hiepe fullname: Hiepe, Falk organization: Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany – sequence: 18 givenname: Søren surname: Jacobsen fullname: Jacobsen, Søren organization: Copenhagen Lupus and Vasculitis Clinic, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark – sequence: 19 givenname: Dinesh surname: Khanna fullname: Khanna, Dinesh organization: Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA – sequence: 20 givenname: Kirsten surname: Lerstrøm fullname: Lerstrøm, Kirsten organization: Lupus Europe, Co-Opted Trustee for Research, Essex, UK – sequence: 21 givenname: Elena surname: Massarotti fullname: Massarotti, Elena organization: Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA – sequence: 22 givenname: Joseph surname: McCune fullname: McCune, Joseph organization: Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA – sequence: 23 givenname: Guillermo orcidid: 0000-0001-7788-1043 surname: Ruiz-Irastorza fullname: Ruiz-Irastorza, Guillermo organization: Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Bizkaia Health Research Institute, Hospital Universitario Cruces, UPV/EHU, Bizkaia, The Basque Country, Spain – sequence: 24 givenname: Jorge surname: Sanchez-Guerrero fullname: Sanchez-Guerrero, Jorge organization: Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico – sequence: 25 givenname: Matthias surname: Schneider fullname: Schneider, Matthias organization: Policlinic and Hiller Research Unit for Rheumatology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany – sequence: 26 givenname: Murray orcidid: 0000-0001-7506-9166 surname: Urowitz fullname: Urowitz, Murray organization: Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto, Lupus Clinic, Toronto, Ontario, Canada – sequence: 27 givenname: George surname: Bertsias fullname: Bertsias, George organization: Rheumatology, Clinical Immunology and Allergy, University of Crete Medical School, Heraklion, Crete, Greece – sequence: 28 givenname: Bimba F surname: Hoyer fullname: Hoyer, Bimba F organization: Department of Medicine III, University of Schleswig-Holstein at Kiel, Kiel, Germany – sequence: 29 givenname: Nicolai surname: Leuchten fullname: Leuchten, Nicolai organization: Medicine III, University Medical Center and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany – sequence: 30 givenname: Chiara surname: Tani fullname: Tani, Chiara organization: Department of Clinical and Experimental Medicine, Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa, Italy – sequence: 31 givenname: Sara K orcidid: 0000-0001-9475-1363 surname: Tedeschi fullname: Tedeschi, Sara K organization: Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA – sequence: 32 givenname: Zahi surname: Touma fullname: Touma, Zahi organization: Division of Rheumatology, Department of Medicine, Toronto Western Hospital, Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada – sequence: 33 givenname: Gabriela surname: Schmajuk fullname: Schmajuk, Gabriela organization: University of California at San Francisco and VA Medical Center, San Francisco, California, USA – sequence: 34 givenname: Branimir surname: Anic fullname: Anic, Branimir organization: Division of Clinical Immunology and Rheumatology, University of Zagreb School of Medicine and University Hospital Centre Zagreb, Zagreb, Croatia – sequence: 35 givenname: Florence orcidid: 0000-0001-6988-6178 surname: Assan fullname: Assan, Florence organization: Department of Rheumatology, Université Paris Sud, Hôpitaux Universitaires Paris-Sud, AP-HP, INSERM UMR 1184, Le Kremlin-Bicêtre, France – sequence: 36 givenname: Tak Mao surname: Chan fullname: Chan, Tak Mao organization: Department of Medicine, University of Hong Kong, Hong Kong, China – sequence: 37 givenname: Ann Elaine surname: Clarke fullname: Clarke, Ann Elaine organization: Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada – sequence: 38 givenname: Mary K surname: Crow fullname: Crow, Mary K organization: Hospital for Special Surgery, Ney York, New York, USA – sequence: 39 givenname: László surname: Czirják fullname: Czirják, László organization: Department of Rheumatology and Immunology, University of Pécs, Pécs, Hungary – sequence: 40 givenname: Andrea orcidid: 0000-0003-0548-4983 surname: Doria fullname: Doria, Andrea organization: Rheumatology Unit, Department of Medicine (DIMED), University of Padova, Padova, Italy – sequence: 41 givenname: Winfried surname: Graninger fullname: Graninger, Winfried organization: Internal Medicine, Medical University of Graz, Graz, Austria – sequence: 42 givenname: Bernadett surname: Halda-Kiss fullname: Halda-Kiss, Bernadett organization: Department of Rheumatology and Immunology, University of Pécs, Pécs, Hungary – sequence: 43 givenname: Sarfaraz surname: Hasni fullname: Hasni, Sarfaraz organization: Lupus Clinical Research Program, Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA – sequence: 44 givenname: Peter M surname: Izmirly fullname: Izmirly, Peter M organization: Rheumatology, New York University School of Medicine, New York, New York, USA – sequence: 45 givenname: Michelle surname: Jung fullname: Jung, Michelle organization: Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada – sequence: 46 givenname: Gábor surname: Kumánovics fullname: Kumánovics, Gábor organization: Department of Rheumatology and Immunology, University of Pécs, Pécs, Hungary – sequence: 47 givenname: Xavier surname: Mariette fullname: Mariette, Xavier organization: Department of Rheumatology, Université Paris-Sud, Center for Immunology of Viral Infections and Auto-immune Diseases (IMVA), Institut pour la Santé et la Recherche Médicale (INSERM) UMR 1184, Université Paris-Saclay, Le Kremlin Bicêtre, France – sequence: 48 givenname: Ivan surname: Padjen fullname: Padjen, Ivan organization: Division of Clinical Immunology and Rheumatology, University of Zagreb School of Medicine and University Hospital Centre Zagreb, Zagreb, Croatia – sequence: 49 givenname: José M surname: Pego-Reigosa fullname: Pego-Reigosa, José M organization: Department of Rheumatology, University Hospital of Vigo, IRIDIS Group, Instituto de Investigación Sanitaria Galicia Sur (IISGS), Vigo, Spain – sequence: 50 givenname: Juanita surname: Romero-Diaz fullname: Romero-Diaz, Juanita organization: Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico – sequence: 51 givenname: Íñigo surname: Rúa-Figueroa Fernández fullname: Rúa-Figueroa Fernández, Íñigo organization: Rheumatology, Doctor Negrín University Hospital, Las Palmas de Gran Canaria, Las Palmas, Spain – sequence: 52 givenname: Raphaèle surname: Seror fullname: Seror, Raphaèle organization: Department of Rheumatology, Université Paris Sud, Hôpitaux Universitaires Paris-Sud, AP-HP, INSERM UMR 1184, Le Kremlin-Bicêtre, France – sequence: 53 givenname: Georg H surname: Stummvoll fullname: Stummvoll, Georg H organization: Rheumatology, Medical University of Vienna, Vienna, Austria – sequence: 54 givenname: Yoshiya orcidid: 0000-0002-0807-7139 surname: Tanaka fullname: Tanaka, Yoshiya organization: First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan – sequence: 55 givenname: Maria G orcidid: 0000-0003-2238-0975 surname: Tektonidou fullname: Tektonidou, Maria G organization: Medical School, National and Kapodistrian University of Athens, Athens, Greece – sequence: 56 givenname: Carlos surname: Vasconcelos fullname: Vasconcelos, Carlos organization: Clinical Immunology Unit, Centro Hospitalar do Porto, ICBAS, University of Porto, Porto, Portugal – sequence: 57 givenname: Edward M surname: Vital fullname: Vital, Edward M organization: NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK – sequence: 58 givenname: Daniel J surname: Wallace fullname: Wallace, Daniel J organization: Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA – sequence: 59 givenname: Sule surname: Yavuz fullname: Yavuz, Sule organization: Department of Rheumatology, Istanbul Bilim University, Istanbul, Turkey – sequence: 60 givenname: Pier Luigi surname: Meroni fullname: Meroni, Pier Luigi organization: Clinical Immunology and Rheumatology Unit, IRCCS Istituto Auxologico Italiano, Milan, Italy – sequence: 61 givenname: Marvin J surname: Fritzler fullname: Fritzler, Marvin J organization: Faculty of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada – sequence: 62 givenname: Ray surname: Naden fullname: Naden, Ray organization: Maternal-Fetal Medicine, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada – sequence: 63 givenname: Thomas orcidid: 0000-0002-6478-7725 surname: Dörner fullname: Dörner, Thomas organization: Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany – sequence: 64 givenname: Sindhu R surname: Johnson fullname: Johnson, Sindhu R email: Sindhu.Johnson@uhn.ca organization: Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31383717$$D View this record in MEDLINE/PubMed |
| BookMark | eNqVkctu1DAYhS1URKeFVwBLbNiE-pKLs2AxGpWCNBISgnXkOH-mHjlx8EVVlrw5TtMW1AWUlfXL32f7HJ-hk9GOgNAbSt5TyssLOY7uGuLQaZ8xQkXGaC5o_QxtaF6miZTkBG0IITzL67I6RWfeH9NIBBUv0CmnXPCKVhv0M9k1vozOTiBHvAd5iIC3B6lHH_DX5Q4ZtB8utgM4rRKys8bAAbDt77etsYcZKyO9131igrYjVk6HZEjcW4f97AMMWmETp-gxuDlcw2L66F-i5700Hl7drefo-8fLb7tP2f7L1efddp-1BSlCVuS8EwogZ1DImhBVF13LyrYkgjHB-pb3leCCMFBFV7dlRWqei6KVJOFccn6OxHpuHCc530hjmsnpQbq5oaRZWm3-aLVZWm3WVpP6blUnZ39E8KEZtFdgjBzBxsSyUtQ5IXS55e0j9GijG1OwhlOSU0Ypzf9GMVYxmhJzlqjXd1RsB-gennv_ewn4sALKWe8d9I3S4bb-4KQ2T8hVPfKf3ghbzXY4_ofEf0sPgf9l_QJeTujP |
| CitedBy_id | crossref_primary_10_1001_jamadermatol_2022_0066 crossref_primary_10_1007_s40272_021_00457_z crossref_primary_10_1002_ccr3_9231 crossref_primary_10_1177_0961203320923398 crossref_primary_10_3390_life13040877 crossref_primary_10_1186_s42358_022_00283_y crossref_primary_10_1016_j_ard_2024_11_006 crossref_primary_10_1093_rheumatology_keab746 crossref_primary_10_1007_s10067_022_06138_7 crossref_primary_10_1055_s_0042_1744363 crossref_primary_10_1038_s41598_023_43350_0 crossref_primary_10_1055_s_0042_1744364 crossref_primary_10_2174_0115733971276106231226071002 crossref_primary_10_3390_ijms23105804 crossref_primary_10_1007_s00296_025_05816_4 crossref_primary_10_1002_ccr3_8145 crossref_primary_10_1016_j_semarthrit_2022_152068 crossref_primary_10_1016_j_nerep_2022_100133 crossref_primary_10_1055_a_1970_6301 crossref_primary_10_1016_j_admp_2023_101808 crossref_primary_10_1097_RHU_0000000000001837 crossref_primary_10_1055_s_0040_1714697 crossref_primary_10_1016_j_imlet_2024_106962 crossref_primary_10_1186_s13075_024_03395_6 crossref_primary_10_1016_j_jaad_2024_12_041 crossref_primary_10_4081_reumatismo_2024_1658 crossref_primary_10_3390_ijms20225799 crossref_primary_10_1093_mr_roab020 crossref_primary_10_1177_09612033241299978 crossref_primary_10_1186_s13075_023_03256_8 crossref_primary_10_1186_s12911_024_02420_7 crossref_primary_10_1080_08916934_2019_1683545 crossref_primary_10_1016_j_autrev_2020_102463 crossref_primary_10_3389_fpubh_2025_1445576 crossref_primary_10_1080_25785826_2025_2481675 crossref_primary_10_3390_diagnostics13111870 crossref_primary_10_1177_09612033221086878 crossref_primary_10_1136_annrheumdis_2019_216695 crossref_primary_10_2147_CEOR_S302404 crossref_primary_10_7326_aimcc_2024_0337 crossref_primary_10_1016_j_reuma_2021_04_002 crossref_primary_10_1111_echo_15921 crossref_primary_10_1093_jalm_jfab142 crossref_primary_10_12998_wjcc_v9_i8_2008 crossref_primary_10_1016_j_autrev_2024_103687 crossref_primary_10_1016_j_med_2021_04_001 crossref_primary_10_1136_bmjopen_2022_064552 crossref_primary_10_1016_j_placenta_2023_06_013 crossref_primary_10_3904_kjm_2020_95_3_151 crossref_primary_10_1002_acr2_11725 crossref_primary_10_1186_s13256_021_02949_5 crossref_primary_10_1002_acr2_11723 crossref_primary_10_1136_annrheumdis_2019_216222 crossref_primary_10_1155_2021_6620701 crossref_primary_10_1038_s41392_025_02168_0 crossref_primary_10_1016_j_autrev_2024_103679 crossref_primary_10_1136_annrheumdis_2020_219373 crossref_primary_10_1016_j_rcreu_2021_03_012 crossref_primary_10_3389_fmed_2021_646846 crossref_primary_10_1016_j_path_2023_04_003 crossref_primary_10_1016_j_semarthrit_2024_152417 crossref_primary_10_2174_1381612828666220512102824 crossref_primary_10_1177_09612033241308105 crossref_primary_10_2174_1573396317666210224144416 crossref_primary_10_1016_j_humimm_2025_111258 crossref_primary_10_1136_rmdopen_2022_002664 crossref_primary_10_1007_s10067_024_06929_0 crossref_primary_10_1016_j_jocmr_2024_101047 crossref_primary_10_1016_j_mjafi_2023_02_007 crossref_primary_10_1007_s10067_023_06682_w crossref_primary_10_1007_s00393_024_01539_2 crossref_primary_10_7759_cureus_10607 crossref_primary_10_3389_fphar_2022_932874 crossref_primary_10_1080_25785826_2020_1770947 crossref_primary_10_1007_s12015_025_10848_1 crossref_primary_10_3389_fimmu_2024_1395609 crossref_primary_10_1142_S2661341723500025 crossref_primary_10_1177_09612033241240864 crossref_primary_10_1186_s13075_024_03397_4 crossref_primary_10_4049_jimmunol_2000905 crossref_primary_10_1016_j_rhum_2023_08_002 crossref_primary_10_1038_s42003_024_05989_x crossref_primary_10_3390_medicina59101841 crossref_primary_10_1007_s00296_020_04552_1 crossref_primary_10_1186_s12890_022_02124_6 crossref_primary_10_1177_09612033231206446 crossref_primary_10_1186_s13023_024_03159_0 crossref_primary_10_1177_0961203320945387 crossref_primary_10_1186_s13317_020_00139_9 crossref_primary_10_1177_09612033231220726 crossref_primary_10_1007_s12026_021_09233_0 crossref_primary_10_1080_25785826_2024_2339542 crossref_primary_10_1038_s41584_023_00948_y crossref_primary_10_3390_ijms241914526 crossref_primary_10_1007_s11926_020_00896_6 crossref_primary_10_1093_mr_roab080 crossref_primary_10_12998_wjcc_v10_i10_3178 crossref_primary_10_3389_fimmu_2021_638863 crossref_primary_10_1136_lupus_2024_001307 crossref_primary_10_1007_s12016_021_08893_y crossref_primary_10_1093_rheumatology_keaa831 crossref_primary_10_1007_s10067_023_06629_1 crossref_primary_10_1177_09612033241240859 crossref_primary_10_1007_s10067_020_05061_z crossref_primary_10_1136_annrheumdis_2020_217162 crossref_primary_10_1136_bmjophth_2023_001608 crossref_primary_10_1177_09612033251317557 crossref_primary_10_1016_j_jbspin_2021_105228 crossref_primary_10_1016_j_rcreu_2021_03_007 crossref_primary_10_7759_cureus_43725 crossref_primary_10_1186_s12886_023_02959_5 crossref_primary_10_1007_s10735_023_10135_8 crossref_primary_10_1097_BOR_0000000000000913 crossref_primary_10_1556_650_2023_32692 crossref_primary_10_3389_fimmu_2023_1080154 crossref_primary_10_3390_jcm12186090 crossref_primary_10_1016_j_jaut_2024_103199 crossref_primary_10_1093_rheumatology_kead097 crossref_primary_10_1177_09612033231208845 crossref_primary_10_3390_jcm13185423 crossref_primary_10_1136_annrheumdis_2020_219314 crossref_primary_10_1093_rheumatology_keaf027 crossref_primary_10_1177_09612033251325321 crossref_primary_10_1016_j_clinph_2024_12_002 crossref_primary_10_1016_j_autrev_2024_103609 crossref_primary_10_1093_rheumatology_kead086 crossref_primary_10_1097_MD_0000000000035374 crossref_primary_10_1016_j_autrev_2024_103604 crossref_primary_10_1093_mrcr_rxac074 crossref_primary_10_1155_jimr_2827348 crossref_primary_10_1007_s10067_024_06893_9 crossref_primary_10_47360_1995_4484_2021_75_83 crossref_primary_10_1177_09612033251325313 crossref_primary_10_3390_jcm14030916 crossref_primary_10_1186_s13223_022_00725_8 crossref_primary_10_1016_j_autrev_2019_102400 crossref_primary_10_1016_j_heliyon_2024_e29230 crossref_primary_10_1111_ddg_15422 crossref_primary_10_1093_mrcr_rxae004 crossref_primary_10_1016_j_semarthrit_2024_152472 crossref_primary_10_1038_s41598_024_58391_2 crossref_primary_10_1093_rheumatology_keaf013 crossref_primary_10_1016_j_ekir_2024_09_028 crossref_primary_10_1002_acr_24795 crossref_primary_10_1136_rmdopen_2024_004395 crossref_primary_10_1016_j_nefro_2022_10_005 crossref_primary_10_3390_jcm11247527 crossref_primary_10_1007_s00296_023_05448_6 crossref_primary_10_1186_s13075_022_02980_x crossref_primary_10_1093_mrcr_rxae032 crossref_primary_10_1093_rheumatology_keae397 crossref_primary_10_3899_jrheum_191409 crossref_primary_10_11144_Javeriana_umed64_1_mono crossref_primary_10_1016_j_jtauto_2021_100139 crossref_primary_10_1111_ddg_14492_g crossref_primary_10_1111_cei_13402 crossref_primary_10_1136_annrheumdis_2020_217105 crossref_primary_10_1186_s13023_022_02445_z crossref_primary_10_1177_09612033231175289 crossref_primary_10_3389_fped_2023_1296426 crossref_primary_10_1136_lupus_2023_000988 crossref_primary_10_1080_1744666X_2022_2033617 crossref_primary_10_1093_rheumatology_kead296 crossref_primary_10_1007_s00296_024_05589_2 crossref_primary_10_1038_s41584_020_00545_3 crossref_primary_10_1136_lupus_2023_000984 crossref_primary_10_1093_mrcr_rxac087 crossref_primary_10_1111_dth_15677 crossref_primary_10_3892_mi_2024_132 crossref_primary_10_1186_s12916_024_03843_9 crossref_primary_10_1016_j_autrev_2024_103650 crossref_primary_10_3390_vaccines10050663 crossref_primary_10_1016_j_jbspin_2022_105357 crossref_primary_10_1177_0961203320917748 crossref_primary_10_3390_biomedicines11113027 crossref_primary_10_1136_annrheumdis_2020_218670 crossref_primary_10_1093_rheumatology_keac199 crossref_primary_10_1136_bcr_2024_263491 crossref_primary_10_1136_annrheumdis_2020_217566 crossref_primary_10_1111_head_14919 crossref_primary_10_5812_ijp_122257 crossref_primary_10_1016_j_ejim_2022_04_001 crossref_primary_10_1177_09612033231176794 crossref_primary_10_1002_brb3_1865 crossref_primary_10_1007_s00392_024_02390_w crossref_primary_10_3389_fimmu_2022_930074 crossref_primary_10_1002_pbc_29481 crossref_primary_10_3389_fimmu_2025_1483815 crossref_primary_10_1016_S1286_935X_24_49136_3 crossref_primary_10_1097_BOR_0000000000000771 crossref_primary_10_1186_s12883_022_02747_6 crossref_primary_10_1097_BOR_0000000000000772 crossref_primary_10_1097_MD_0000000000032077 crossref_primary_10_1038_s41591_022_02017_5 crossref_primary_10_3390_jcm10204788 crossref_primary_10_1016_j_autrev_2023_103356 crossref_primary_10_2215_CJN_0000000000000438 crossref_primary_10_1007_s00296_024_05696_0 crossref_primary_10_1007_s13760_023_02276_0 crossref_primary_10_1080_03009742_2023_2240586 crossref_primary_10_1186_s43166_023_00222_9 crossref_primary_10_1080_1744666X_2024_2324005 crossref_primary_10_1111_ncn3_12762 crossref_primary_10_1126_scitranslmed_abn2263 crossref_primary_10_1136_annrheumdis_2019_216259 crossref_primary_10_1136_annrheumdis_2019_216253 crossref_primary_10_1007_s00393_020_00773_8 crossref_primary_10_1093_rheumatology_keae349 crossref_primary_10_1111_1756_185X_14767 crossref_primary_10_1016_j_heliyon_2023_e23213 crossref_primary_10_1186_s13099_025_00683_7 crossref_primary_10_1007_s00108_023_01624_9 crossref_primary_10_3389_fphar_2022_898049 crossref_primary_10_1007_s00393_023_01359_w crossref_primary_10_1136_ard_2024_226528 crossref_primary_10_1016_j_medcle_2022_04_008 crossref_primary_10_1016_j_medcli_2022_04_002 crossref_primary_10_1093_rheumatology_keae583 crossref_primary_10_1007_s40620_020_00938_3 crossref_primary_10_1016_j_intimp_2022_109231 crossref_primary_10_15406_jpnc_2024_14_00549 crossref_primary_10_1080_03007995_2022_2159146 crossref_primary_10_1038_s41598_024_80104_y crossref_primary_10_3390_diagnostics12112605 crossref_primary_10_3390_cells12030355 crossref_primary_10_1055_a_1037_5326 crossref_primary_10_1007_s11845_023_03420_8 crossref_primary_10_1136_lupus_2021_000474 crossref_primary_10_3390_ph14030276 crossref_primary_10_4103_jcrt_jcrt_279_23 crossref_primary_10_22141_2224_0551_18_4_2023_1603 crossref_primary_10_1126_sciimmunol_adi9769 crossref_primary_10_1177_0961203320988586 crossref_primary_10_3899_jrheum_200871 crossref_primary_10_7759_cureus_35304 crossref_primary_10_1016_j_medcli_2024_09_033 crossref_primary_10_1016_S1474_4422_24_00288_6 crossref_primary_10_1136_lupus_2024_001162 crossref_primary_10_1016_j_jaut_2021_102707 crossref_primary_10_1186_s43054_023_00205_7 crossref_primary_10_1186_s12931_025_03169_x crossref_primary_10_1136_lupus_2022_000742 crossref_primary_10_1136_lupus_2021_000488 crossref_primary_10_1177_09612033241272953 crossref_primary_10_1016_j_clim_2020_108445 crossref_primary_10_1080_07853890_2024_2392882 crossref_primary_10_1093_rheumatology_kead224 crossref_primary_10_1177_0300060520903659 crossref_primary_10_1136_lupus_2024_001196 crossref_primary_10_3389_fimmu_2024_1504624 crossref_primary_10_1080_1744666X_2023_2292188 crossref_primary_10_7759_cureus_30089 crossref_primary_10_1002_acr_24152 crossref_primary_10_1136_bcr_2020_241391 crossref_primary_10_20986_revesppod_2023_1674_2023 crossref_primary_10_1134_S1607672924700911 crossref_primary_10_1016_j_semarthrit_2025_152684 crossref_primary_10_1038_s41598_020_79544_z crossref_primary_10_1177_09612033241272964 crossref_primary_10_1186_s13256_022_03478_5 crossref_primary_10_3390_ijerph191911910 crossref_primary_10_1177_09612033221115618 crossref_primary_10_3390_app15031590 crossref_primary_10_3390_jcm12124059 crossref_primary_10_1016_j_rhum_2021_10_003 crossref_primary_10_3389_fendo_2024_1368088 crossref_primary_10_1007_s10067_020_05010_w crossref_primary_10_1007_s12519_023_00748_0 crossref_primary_10_1093_rheumatology_keac120 crossref_primary_10_3389_fimmu_2024_1374100 crossref_primary_10_3389_fimmu_2021_631539 crossref_primary_10_1080_25785826_2025_2460275 crossref_primary_10_1155_2021_3666270 crossref_primary_10_1016_j_ejim_2022_12_019 crossref_primary_10_1177_09612033231168477 crossref_primary_10_1056_NEJMoa2308917 crossref_primary_10_1002_cti2_1293 crossref_primary_10_1016_j_oftale_2023_01_002 crossref_primary_10_1542_pir_2021_005259 crossref_primary_10_7759_cureus_15517 crossref_primary_10_1186_s12882_020_02140_w crossref_primary_10_1055_s_0044_1791699 crossref_primary_10_1136_lupus_2020_000389 crossref_primary_10_2967_jnumed_124_268643 crossref_primary_10_3389_fphar_2025_1484320 crossref_primary_10_1136_ard_2023_224692 crossref_primary_10_1177_03000605231173275 crossref_primary_10_1002_acr_25288 crossref_primary_10_1089_scd_2020_0194 crossref_primary_10_1136_annrheumdis_2021_221374 crossref_primary_10_1002_ajim_23313 crossref_primary_10_1002_iid3_918 crossref_primary_10_3389_fimmu_2022_964901 crossref_primary_10_1007_s10067_024_07067_3 crossref_primary_10_1016_j_rcreu_2024_04_007 crossref_primary_10_1111_ene_14390 crossref_primary_10_1111_imm_13434 crossref_primary_10_1111_1759_7714_14368 crossref_primary_10_1016_j_gene_2024_149004 crossref_primary_10_1093_rheumatology_keaa381 crossref_primary_10_1016_j_jdcr_2022_03_015 crossref_primary_10_1177_0961203321995242 crossref_primary_10_3390_ijms24032259 crossref_primary_10_1016_j_eclinm_2024_102476 crossref_primary_10_3390_cells12202489 crossref_primary_10_1016_j_tcm_2022_02_002 crossref_primary_10_1111_1756_185X_14245 crossref_primary_10_1182_blood_2023020727 crossref_primary_10_1016_j_clim_2021_108765 crossref_primary_10_1016_j_humimm_2022_03_010 crossref_primary_10_1002_jgm_3399 crossref_primary_10_7759_cureus_9739 crossref_primary_10_1016_j_intimp_2023_110968 crossref_primary_10_1177_09612033221149884 crossref_primary_10_1016_S2665_9913_24_00348_5 crossref_primary_10_1093_rheumatology_kead644 crossref_primary_10_1136_bcr_2019_233330 crossref_primary_10_1007_s10067_024_07101_4 crossref_primary_10_1093_rheumatology_kead406 crossref_primary_10_1007_s11298_021_1926_1 crossref_primary_10_1016_j_ekir_2020_09_007 crossref_primary_10_1016_j_jneuroim_2020_577144 crossref_primary_10_1093_rheumatology_kead407 crossref_primary_10_1136_annrheumdis_2021_220262 crossref_primary_10_15263_jlmqa_2022_44_1_21 crossref_primary_10_1155_2021_8491717 crossref_primary_10_1093_mr_roac060 crossref_primary_10_1186_s13075_023_03010_0 crossref_primary_10_1136_annrheumdis_2019_216712 crossref_primary_10_1016_j_semarthrit_2022_152103 crossref_primary_10_1093_rheumatology_keaa379 crossref_primary_10_1186_s12969_021_00619_w crossref_primary_10_3390_biomedicines12071552 crossref_primary_10_3389_fmed_2024_1338947 crossref_primary_10_1155_2022_8081055 crossref_primary_10_1093_rheumatology_keab216 crossref_primary_10_1093_rheumatology_keab217 crossref_primary_10_1177_09612033241260334 crossref_primary_10_1016_j_heliyon_2024_e24105 crossref_primary_10_1080_25785826_2020_1796285 crossref_primary_10_1515_cclm_2022_1136 crossref_primary_10_1186_s13075_024_03305_w crossref_primary_10_1186_s12969_021_00552_y crossref_primary_10_1111_1756_185X_14269 crossref_primary_10_3389_fped_2024_1425874 crossref_primary_10_1186_s13317_020_00138_w crossref_primary_10_2217_bmm_2023_0774 crossref_primary_10_1093_qjmed_hcab304 crossref_primary_10_1177_03000605241244761 crossref_primary_10_1007_s11560_021_00519_w crossref_primary_10_1007_s10067_020_05252_8 crossref_primary_10_1177_09612033251317357 crossref_primary_10_3389_fneur_2023_1111769 crossref_primary_10_51847_gz8DAMBMnZ crossref_primary_10_2147_OARRR_S306503 crossref_primary_10_1038_s41584_020_0480_7 crossref_primary_10_1177_0961203320966378 crossref_primary_10_1016_S2665_9913_20_30097_7 crossref_primary_10_3389_fimmu_2025_1525892 crossref_primary_10_1177_0961203321991920 crossref_primary_10_1007_s00296_021_05018_8 crossref_primary_10_1212_CON_0000000000001390 crossref_primary_10_1186_s13075_024_03460_0 crossref_primary_10_3389_fped_2024_1348342 crossref_primary_10_3389_fmed_2022_1093213 crossref_primary_10_1111_resp_13977 crossref_primary_10_1177_09612033241238053 crossref_primary_10_1007_s40744_021_00336_6 crossref_primary_10_1016_j_jaad_2024_01_041 crossref_primary_10_1136_lupus_2022_000718 crossref_primary_10_1136_annrheumdis_2020_216924 crossref_primary_10_1177_1759720X231181336 crossref_primary_10_1007_s13340_024_00772_z crossref_primary_10_2478_aite_2025_0002 crossref_primary_10_26442_00403660_2021_05_200799 crossref_primary_10_1515_almed_2020_0067 crossref_primary_10_1016_j_reuma_2022_08_001 crossref_primary_10_1093_rheumatology_keaa575 crossref_primary_10_1186_s12886_024_03760_8 crossref_primary_10_1177_09612033241240588 crossref_primary_10_1016_j_heliyon_2024_e30608 crossref_primary_10_1093_cei_uxae073 crossref_primary_10_1177_09612033241298729 crossref_primary_10_3389_fmed_2022_903608 crossref_primary_10_1016_j_ejim_2021_06_012 crossref_primary_10_1080_14397595_2020_1829341 crossref_primary_10_1007_s00431_020_03910_2 crossref_primary_10_3390_jcm13195831 crossref_primary_10_3390_clinpract14020037 crossref_primary_10_1007_s00431_024_05662_9 crossref_primary_10_1016_j_jtauto_2023_100191 crossref_primary_10_1111_1756_185X_15150 crossref_primary_10_1016_j_ultrasmedbio_2022_12_010 crossref_primary_10_3390_biomedicines12092047 crossref_primary_10_1093_rheumatology_keaa321 crossref_primary_10_3390_ijms21114120 crossref_primary_10_1055_a_1489_6248 crossref_primary_10_1016_j_berh_2024_101949 crossref_primary_10_1111_jdv_17514 crossref_primary_10_1016_j_reumae_2022_06_006 crossref_primary_10_1055_a_1913_4010 crossref_primary_10_1007_s10067_023_06758_7 crossref_primary_10_1177_09612033221094707 crossref_primary_10_1093_mr_roae062 crossref_primary_10_1177_09612033221094706 crossref_primary_10_1007_s40265_024_02043_2 crossref_primary_10_1016_j_medcli_2020_05_009 crossref_primary_10_1186_s12891_024_07367_4 crossref_primary_10_3390_jcm12041295 crossref_primary_10_7759_cureus_29287 crossref_primary_10_1016_j_nefroe_2023_05_006 crossref_primary_10_1093_rheumatology_keab875 crossref_primary_10_1016_j_berh_2023_101895 crossref_primary_10_1055_a_2517_5956 crossref_primary_10_1007_s11882_020_00906_8 crossref_primary_10_1007_s40744_022_00442_z crossref_primary_10_1136_annrheumdis_2019_216700 crossref_primary_10_1093_rheumatology_keaa788 crossref_primary_10_1155_2022_9698138 crossref_primary_10_4103_jdrntruhs_jdrntruhs_129_21 crossref_primary_10_1177_09612033211014570 crossref_primary_10_1007_s12026_024_09543_z crossref_primary_10_1111_1756_185X_15175 crossref_primary_10_1172_jci_insight_147789 crossref_primary_10_1038_s41584_021_00710_2 crossref_primary_10_1186_s40001_023_01022_9 crossref_primary_10_1080_09273948_2022_2029497 crossref_primary_10_1016_j_autrev_2021_102882 crossref_primary_10_1016_j_intimp_2024_112886 crossref_primary_10_1016_j_autrev_2023_103294 crossref_primary_10_1016_j_cden_2023_05_018 crossref_primary_10_1016_j_autrev_2023_103295 crossref_primary_10_1186_s13075_019_2034_4 crossref_primary_10_1186_s12879_024_09757_4 crossref_primary_10_3389_fimmu_2022_1020891 crossref_primary_10_1177_09612033221083267 crossref_primary_10_3389_fcell_2020_592490 crossref_primary_10_1016_j_medcli_2023_03_015 crossref_primary_10_1007_s42000_023_00463_5 crossref_primary_10_3389_fmed_2022_1097528 crossref_primary_10_1177_09612033221076739 crossref_primary_10_2215_CJN_0000000000000185 crossref_primary_10_2147_JIR_S418598 crossref_primary_10_1097_MD_0000000000035418 crossref_primary_10_3390_ijms26031091 crossref_primary_10_1093_rheumatology_keab611 crossref_primary_10_1007_s00417_024_06461_6 crossref_primary_10_1016_j_pdpdt_2024_104406 crossref_primary_10_1016_j_banm_2021_10_006 crossref_primary_10_1016_j_jaut_2022_102889 crossref_primary_10_3390_jcm10020243 crossref_primary_10_1097_CM9_0000000000000983 crossref_primary_10_1016_j_medcle_2020_05_027 crossref_primary_10_1093_rheumatology_keaa767 crossref_primary_10_1038_s41598_024_60217_0 crossref_primary_10_2147_CCID_S403866 crossref_primary_10_1080_25785826_2024_2370083 crossref_primary_10_1097_MS9_0000000000001502 crossref_primary_10_1016_j_jaad_2023_01_020 crossref_primary_10_1016_j_medcle_2023_11_031 crossref_primary_10_12677_ACM_2023_13102149 crossref_primary_10_1007_s00108_023_01554_6 crossref_primary_10_1016_j_ijmedinf_2025_105839 crossref_primary_10_1016_j_semarthrit_2024_152516 crossref_primary_10_1097_NRL_0000000000000520 crossref_primary_10_1016_j_jtauto_2024_100244 crossref_primary_10_1097_BOR_0000000000000825 crossref_primary_10_1177_09612033241230734 crossref_primary_10_5114_reum_199640 crossref_primary_10_1177_09612033241230736 crossref_primary_10_1136_annrheumdis_2019_216337 crossref_primary_10_1136_annrheumdis_2019_216338 crossref_primary_10_1016_j_jen_2022_12_012 crossref_primary_10_1055_a_1294_1205 crossref_primary_10_3389_fimmu_2022_953439 crossref_primary_10_1111_jdv_20031 crossref_primary_10_1136_rmdopen_2023_003981 crossref_primary_10_1016_j_cca_2023_117750 crossref_primary_10_1186_s13075_024_03298_6 crossref_primary_10_1016_j_medcle_2023_03_033 crossref_primary_10_1007_s12185_020_02914_w crossref_primary_10_1016_j_semarthrit_2024_152536 crossref_primary_10_1186_s42358_023_00344_w crossref_primary_10_1002_path_6174 crossref_primary_10_1186_s12974_024_03085_9 crossref_primary_10_1002_acr_24849 crossref_primary_10_3389_fimmu_2025_1506298 crossref_primary_10_1136_lupus_2023_001125 crossref_primary_10_3390_jcm10194516 crossref_primary_10_1007_s11604_021_01154_0 crossref_primary_10_1136_lupus_2024_001402 crossref_primary_10_1111_sji_13220 crossref_primary_10_1136_ard_2024_226226 crossref_primary_10_1002_ehf2_12806 crossref_primary_10_1177_1753495X21990216 crossref_primary_10_1186_s12865_021_00469_x crossref_primary_10_1016_j_jaut_2022_102845 crossref_primary_10_1055_a_1121_8852 crossref_primary_10_1002_acr2_11674 crossref_primary_10_1016_j_bcp_2024_116578 crossref_primary_10_1016_j_berh_2025_102042 crossref_primary_10_3389_fdgth_2024_1344103 crossref_primary_10_3389_fmed_2025_1558702 crossref_primary_10_1016_j_semarthrit_2024_152556 crossref_primary_10_1007_s00393_020_00802_6 crossref_primary_10_1016_j_reuma_2022_06_003 crossref_primary_10_1186_s13362_022_00119_w crossref_primary_10_1093_jalm_jfab098 crossref_primary_10_1136_ard_2022_222549 crossref_primary_10_1007_s15202_021_4640_7 crossref_primary_10_1016_j_medcli_2023_11_037 crossref_primary_10_3389_fimmu_2024_1380481 crossref_primary_10_1007_s00296_023_05279_5 crossref_primary_10_1007_s10067_021_05989_w crossref_primary_10_1177_09612033241249791 crossref_primary_10_1093_rheumatology_keae070 crossref_primary_10_1136_bcr_2023_259199 crossref_primary_10_1155_2024_5593302 crossref_primary_10_1016_j_semarthrit_2024_152568 crossref_primary_10_1177_0961203321990106 crossref_primary_10_1136_lupus_2023_001106 crossref_primary_10_1016_j_jaut_2022_102869 crossref_primary_10_31083_j_fbl2710282 crossref_primary_10_1007_s10554_024_03047_5 crossref_primary_10_1007_s10067_024_06917_4 crossref_primary_10_1007_s40744_020_00212_9 crossref_primary_10_1016_j_semarthrit_2020_11_006 crossref_primary_10_1038_s41598_024_65105_1 crossref_primary_10_3389_fimmu_2023_1257906 crossref_primary_10_1177_0961203320984251 crossref_primary_10_1136_bcr_2021_246533 crossref_primary_10_1186_s13317_020_0127_3 crossref_primary_10_1016_j_ejr_2023_08_004 crossref_primary_10_1177_0961203320950017 crossref_primary_10_1002_acr_24898 crossref_primary_10_1016_j_ebiom_2022_103883 crossref_primary_10_1080_17843286_2021_1925817 crossref_primary_10_1186_s12884_024_06701_x crossref_primary_10_1136_annrheumdis_2020_217017 crossref_primary_10_1016_j_clim_2022_109031 crossref_primary_10_1016_S0992_5945_23_00100_9 crossref_primary_10_1016_j_semarthrit_2019_09_009 crossref_primary_10_1080_1744666X_2023_2260098 crossref_primary_10_1016_j_ejr_2021_02_004 crossref_primary_10_3389_fmed_2024_1455673 crossref_primary_10_1136_annrheumdis_2019_216155 crossref_primary_10_1016_j_clim_2021_108907 crossref_primary_10_3389_fimmu_2022_966591 crossref_primary_10_1016_j_ejr_2024_12_003 crossref_primary_10_1186_s13075_024_03330_9 crossref_primary_10_3390_healthcare10091664 crossref_primary_10_1136_rmdopen_2024_005118 crossref_primary_10_1007_s11926_021_00985_0 crossref_primary_10_3390_sclerosis1010006 crossref_primary_10_1097_MD_0000000000036356 crossref_primary_10_1093_mrcr_rxad036 crossref_primary_10_3390_nu16121974 crossref_primary_10_12968_hmed_2024_0108 crossref_primary_10_1016_j_rdc_2021_04_011 crossref_primary_10_1186_s12890_023_02360_4 crossref_primary_10_3892_br_2025_1936 crossref_primary_10_2139_ssrn_4101028 crossref_primary_10_1016_j_autrev_2020_102739 crossref_primary_10_1002_iid3_70022 crossref_primary_10_1177_03000605221118702 crossref_primary_10_1177_09612033211066462 crossref_primary_10_1093_mrcr_rxaf006 crossref_primary_10_1186_s13075_021_02694_6 crossref_primary_10_1186_s12890_024_03081_y crossref_primary_10_1001_jamadermatol_2022_5221 crossref_primary_10_1177_09612033231153791 crossref_primary_10_1186_s13075_023_03202_8 crossref_primary_10_1136_rmdopen_2019_001097 crossref_primary_10_3389_fimmu_2023_1235937 crossref_primary_10_1155_2021_5579608 crossref_primary_10_1515_almed_2021_0008 crossref_primary_10_1007_s00296_022_05182_5 crossref_primary_10_3390_ijms25105351 crossref_primary_10_1016_j_autrev_2020_102508 crossref_primary_10_3390_life11050457 crossref_primary_10_4078_jrd_2024_0050 crossref_primary_10_1002_acr_24213 crossref_primary_10_1016_j_autrev_2024_103535 crossref_primary_10_4103_MJBL_MJBL_697_23 crossref_primary_10_1038_s41584_020_00522_w crossref_primary_10_3389_fendo_2024_1351197 crossref_primary_10_3389_fimmu_2024_1503434 crossref_primary_10_3390_diagnostics14111186 crossref_primary_10_1136_annrheumdis_2020_218546 crossref_primary_10_1177_10815589231171404 crossref_primary_10_3389_fpsyt_2023_1078607 crossref_primary_10_12998_wjcc_v11_i2_456 crossref_primary_10_1136_bcr_2020_237341 crossref_primary_10_3389_fimmu_2024_1454691 crossref_primary_10_1093_rheumatology_kead166 crossref_primary_10_3389_fimmu_2024_1425847 crossref_primary_10_1016_j_autrev_2022_103144 crossref_primary_10_1097_JCMA_0000000000001009 crossref_primary_10_1055_a_2508_1112 crossref_primary_10_1111_ddg_14492 crossref_primary_10_3390_jcm11154316 crossref_primary_10_1177_0961203320979051 crossref_primary_10_1016_j_heliyon_2024_e32118 crossref_primary_10_1001_jama_2024_2315 crossref_primary_10_1016_j_autrev_2022_103138 crossref_primary_10_1016_j_mayocp_2024_10_001 crossref_primary_10_1093_rheumatology_keac064 crossref_primary_10_2196_18291 crossref_primary_10_1007_s12688_021_00484_1 crossref_primary_10_1136_ard_2023_225266 crossref_primary_10_1136_ard_2024_225785 crossref_primary_10_3389_fgwh_2022_1031190 crossref_primary_10_1007_s00403_024_03610_z crossref_primary_10_1111_1756_185X_14894 crossref_primary_10_1007_s00393_024_01551_6 crossref_primary_10_3897_pharmacia_72_e132051 crossref_primary_10_1016_j_thromres_2023_02_005 crossref_primary_10_1177_1721727X231194240 crossref_primary_10_53730_ijhs_v4nS1_15215 crossref_primary_10_3389_fimmu_2022_957201 crossref_primary_10_7556_jaoa_2020_137 crossref_primary_10_1186_s13075_021_02696_4 crossref_primary_10_1093_rheumatology_keae231 crossref_primary_10_1016_j_ejr_2023_06_002 crossref_primary_10_1093_rheumatology_keac055 crossref_primary_10_1016_j_bbi_2024_04_001 crossref_primary_10_3389_fcell_2021_696559 crossref_primary_10_1136_ard_2023_225013 crossref_primary_10_1007_s11255_024_04105_6 crossref_primary_10_1007_s10067_025_07348_5 crossref_primary_10_1097_JDN_0000000000000783 crossref_primary_10_3389_fped_2024_1341188 crossref_primary_10_3390_jcm14051735 crossref_primary_10_1056_NEJMoa2118025 crossref_primary_10_1016_j_oftal_2022_12_003 crossref_primary_10_1515_cclm_2020_1408 crossref_primary_10_3390_nu11112629 crossref_primary_10_1111_1756_185X_14644 crossref_primary_10_1177_0961203320908932 crossref_primary_10_1016_S2665_9913_21_00370_2 crossref_primary_10_3947_ic_2022_0115 crossref_primary_10_1016_j_autrev_2022_103213 crossref_primary_10_1056_NEJMcpc2100271 crossref_primary_10_1016_j_intimp_2023_110866 crossref_primary_10_3390_cimb45120617 crossref_primary_10_1016_j_jtauto_2022_100143 crossref_primary_10_1016_j_jtauto_2022_100141 crossref_primary_10_1177_09612033241281783 crossref_primary_10_1016_j_jtauto_2022_100145 crossref_primary_10_3389_fimmu_2024_1475073 crossref_primary_10_1016_j_smim_2022_101653 crossref_primary_10_1016_j_reuma_2025_501842 crossref_primary_10_1093_rheumatology_keac275 crossref_primary_10_1093_mrcr_rxab020 crossref_primary_10_1093_rheumatology_keae453 crossref_primary_10_3899_jrheum_220100 crossref_primary_10_1111_1744_9987_14144 crossref_primary_10_1016_j_clim_2023_109286 crossref_primary_10_1155_2021_6681590 crossref_primary_10_1136_annrheumdis_2020_217769 crossref_primary_10_1136_annrheumdis_2020_218615 crossref_primary_10_1038_s41572_019_0141_9 crossref_primary_10_1177_03946320221101287 crossref_primary_10_1136_lupus_2023_000924 crossref_primary_10_3390_healthcare12161633 crossref_primary_10_1007_s10875_024_01696_8 crossref_primary_10_1016_j_annder_2023_04_002 crossref_primary_10_1007_s12185_021_03243_2 crossref_primary_10_1016_j_jid_2024_11_022 crossref_primary_10_1016_j_rcreue_2021_03_001 crossref_primary_10_1055_a_1165_1725 crossref_primary_10_3389_fimmu_2024_1340224 crossref_primary_10_1016_j_brainres_2022_148203 crossref_primary_10_1111_aogs_14880 crossref_primary_10_1136_rmdopen_2024_004437 crossref_primary_10_1080_08916934_2024_2360490 crossref_primary_10_1155_2022_3833649 crossref_primary_10_1007_s12016_020_08817_2 crossref_primary_10_1177_03000605221115390 crossref_primary_10_1007_s10067_025_07392_1 crossref_primary_10_1177_09612033241245549 crossref_primary_10_34883_PI_2020_2_2_049 crossref_primary_10_1007_s12098_023_04833_0 crossref_primary_10_1093_rheumatology_keac005 crossref_primary_10_1111_1346_8138_17355 crossref_primary_10_1007_s00393_021_01116_x crossref_primary_10_1136_ard_2023_224762 crossref_primary_10_1016_j_cca_2024_119681 crossref_primary_10_1016_j_clinbiomech_2024_106372 crossref_primary_10_3390_jcm13041100 crossref_primary_10_3389_fphar_2021_722017 crossref_primary_10_1093_qjmed_hcad204 crossref_primary_10_2147_JIR_S365399 crossref_primary_10_1007_s12026_023_09430_z crossref_primary_10_1177_09612033221126866 crossref_primary_10_2147_PGPM_S476308 crossref_primary_10_1002_rai2_12148 crossref_primary_10_2147_JIR_S275043 crossref_primary_10_7759_cureus_24349 crossref_primary_10_1007_s00393_024_01554_3 crossref_primary_10_1016_j_clim_2021_108898 crossref_primary_10_1111_1751_2980_13307 crossref_primary_10_1007_s10067_024_07231_9 crossref_primary_10_3899_jrheum_190933 crossref_primary_10_1136_lupus_2021_000555 crossref_primary_10_1038_s42003_021_02000_9 crossref_primary_10_1007_s10238_024_01503_z crossref_primary_10_7759_cureus_59851 crossref_primary_10_1093_rheumatology_kead558 crossref_primary_10_4103_NJM_NJM_2_20 crossref_primary_10_1007_s10238_021_00707_x crossref_primary_10_1080_1744666X_2020_1805316 crossref_primary_10_1136_annrheumdis_2021_221288 crossref_primary_10_3389_fimmu_2022_1023451 crossref_primary_10_1093_pch_pxab113 crossref_primary_10_1055_a_1469_2433 crossref_primary_10_1136_lupus_2021_000560 crossref_primary_10_1007_s40259_023_00597_3 crossref_primary_10_1002_dc_24450 crossref_primary_10_4103_jcecho_jcecho_59_24 crossref_primary_10_1111_ddg_15422_g crossref_primary_10_1177_09612033241261746 crossref_primary_10_1136_bcr_2020_241449 crossref_primary_10_1093_ckj_sfad055 crossref_primary_10_1186_s12969_024_01045_4 crossref_primary_10_1136_lupus_2023_000963 crossref_primary_10_4103_jfmpc_jfmpc_569_22 crossref_primary_10_3390_biom11091378 crossref_primary_10_1002_acr_24078 crossref_primary_10_3389_fmed_2022_1044856 crossref_primary_10_3390_cimb46080509 crossref_primary_10_1136_annrheumdis_2021_221014 crossref_primary_10_1007_s00296_020_04766_3 crossref_primary_10_1186_s12969_023_00945_1 crossref_primary_10_1007_s10067_019_04848_z crossref_primary_10_1007_s10238_024_01438_5 crossref_primary_10_1016_j_clim_2022_108953 crossref_primary_10_1212_CON_0000000000001459 crossref_primary_10_1177_1759720X221086719 crossref_primary_10_14412_1995_4484_2020_5_14 crossref_primary_10_3390_diagnostics12030647 crossref_primary_10_7759_cureus_16945 crossref_primary_10_3390_ijms24076156 crossref_primary_10_1016_j_jaad_2022_09_028 crossref_primary_10_1186_s43166_021_00103_z crossref_primary_10_1093_rheumatology_kez477 crossref_primary_10_1097_MPH_0000000000003011 crossref_primary_10_7759_cureus_80437 crossref_primary_10_1111_pde_15213 crossref_primary_10_1016_j_asjsur_2023_05_172 crossref_primary_10_1097_RHU_0000000000002196 crossref_primary_10_12998_wjcc_v11_i4_909 crossref_primary_10_1136_lupus_2022_000880 crossref_primary_10_1016_j_reumae_2023_05_003 crossref_primary_10_3390_diagnostics14232681 crossref_primary_10_1093_rap_rkae029 crossref_primary_10_1097_MD_0000000000034079 crossref_primary_10_3390_biomedicines10102423 crossref_primary_10_1097_WCO_0000000000001047 crossref_primary_10_1016_j_rmclc_2021_05_004 crossref_primary_10_1136_bmj_2022_073980 crossref_primary_10_1177_09612033231169896 crossref_primary_10_1177_09612033211050340 crossref_primary_10_1093_intimm_dxad027 crossref_primary_10_3899_jrheum_2023_0964 crossref_primary_10_1016_j_reumae_2021_04_016 crossref_primary_10_1093_rheumatology_keac437 crossref_primary_10_1016_j_heliyon_2024_e38880 crossref_primary_10_1097_IAE_0000000000003185 crossref_primary_10_1136_lupus_2024_001207 crossref_primary_10_1136_rmdopen_2023_003431 crossref_primary_10_1016_j_ejim_2023_03_014 crossref_primary_10_1007_s11239_020_02295_1 crossref_primary_10_1007_s11560_020_00483_x crossref_primary_10_1016_j_jaut_2019_102356 crossref_primary_10_1093_rap_rkaa011 crossref_primary_10_1136_lupus_2024_001202 crossref_primary_10_1136_lupus_2021_000516 crossref_primary_10_1136_lupus_2021_000513 crossref_primary_10_1007_s10067_024_07257_z crossref_primary_10_23736_S1825_859X_21_00088_8 crossref_primary_10_3390_pathogens13110934 crossref_primary_10_1186_s13256_025_05119_z crossref_primary_10_1177_09612033221139788 crossref_primary_10_1186_s12969_022_00722_6 crossref_primary_10_1177_09612033231171343 crossref_primary_10_1007_s00256_025_04896_4 crossref_primary_10_1016_j_jtauto_2025_100274 crossref_primary_10_7759_cureus_16076 crossref_primary_10_1007_s00296_023_05331_4 crossref_primary_10_1007_s00393_023_01319_4 crossref_primary_10_1177_09612033211050337 crossref_primary_10_3348_jksr_2021_0039 crossref_primary_10_1007_s11926_020_00906_7 crossref_primary_10_1093_rheumatology_keaa484 crossref_primary_10_1002_art_42775 crossref_primary_10_1080_17460441_2022_2050691 crossref_primary_10_1002_art_42778 crossref_primary_10_1002_tre_876 crossref_primary_10_1093_rheumatology_keac653 crossref_primary_10_3389_fimmu_2024_1369969 crossref_primary_10_3389_fimmu_2023_1223062 crossref_primary_10_1136_annrheumdis_2021_220363 crossref_primary_10_3390_bios14020098 crossref_primary_10_2147_CCID_S378985 crossref_primary_10_1136_lupus_2021_000531 crossref_primary_10_1016_S2665_9913_24_00160_7 crossref_primary_10_1093_mr_road056 crossref_primary_10_1007_s00393_024_01534_7 crossref_primary_10_1016_j_jaut_2019_102374 crossref_primary_10_1016_j_pedn_2022_09_017 crossref_primary_10_3390_antib13010021 crossref_primary_10_1007_s10157_024_02569_5 crossref_primary_10_3390_cimb45050275 crossref_primary_10_1093_rheumatology_keac641 crossref_primary_10_1007_s10792_024_03016_w crossref_primary_10_1097_RHU_0000000000001464 crossref_primary_10_3390_cells10082128 crossref_primary_10_1016_j_rcreu_2024_11_002 crossref_primary_10_1177_1759720X221089586 crossref_primary_10_1016_j_ejr_2023_09_003 crossref_primary_10_1177_0961203320959716 crossref_primary_10_23736_S1825_859X_22_00141_4 crossref_primary_10_3390_diagnostics11071139 crossref_primary_10_3389_fimmu_2020_02084 crossref_primary_10_3390_jpm12121955 crossref_primary_10_5021_ad_23_126 crossref_primary_10_1542_pir_2021_004930 crossref_primary_10_1136_lupus_2024_001213 crossref_primary_10_3389_fped_2024_1469912 crossref_primary_10_1007_s10238_023_01094_1 crossref_primary_10_1001_jamanetworkopen_2024_32131 crossref_primary_10_1007_s10072_020_04429_y crossref_primary_10_1111_bjh_18732 crossref_primary_10_1177_09733698241231339 crossref_primary_10_1093_rheumatology_keab306 crossref_primary_10_1186_s13023_024_03077_1 crossref_primary_10_1016_j_rhum_2023_06_007 crossref_primary_10_1093_labmed_lmae035 crossref_primary_10_1186_s12969_024_00975_3 crossref_primary_10_1016_j_jneuroim_2020_577229 crossref_primary_10_4997_jrcpe_2021_324 crossref_primary_10_1038_s41584_021_00668_1 crossref_primary_10_1038_s41598_024_69228_3 crossref_primary_10_1126_sciadv_abo5840 crossref_primary_10_1016_j_ijcard_2022_06_040 crossref_primary_10_1136_annrheumdis_2020_219069 crossref_primary_10_3390_ijms24076578 crossref_primary_10_1136_rmdopen_2021_001902 crossref_primary_10_33920_med_01_2410_04 crossref_primary_10_1093_rheumatology_keac626 crossref_primary_10_26442_00403660_2023_05_202246 crossref_primary_10_3390_jpm13050763 crossref_primary_10_1177_09612033211013584 crossref_primary_10_1111_1756_185X_14187 crossref_primary_10_1016_j_mpmed_2021_10_003 crossref_primary_10_12968_bjon_2022_31_7_348 crossref_primary_10_1177_0961203320935988 crossref_primary_10_1093_jalm_jfab132 crossref_primary_10_1177_11206721221098284 crossref_primary_10_18699_SSMJ20230619 crossref_primary_10_1136_annrheumdis_2019_216803 crossref_primary_10_1093_rheumatology_kead707 crossref_primary_10_1159_000536580 crossref_primary_10_3390_jcm11206016 crossref_primary_10_3390_jcm13206242 crossref_primary_10_3899_jrheum_200726 crossref_primary_10_1007_s00393_023_01461_z crossref_primary_10_1136_annrheumdis_2019_216807 crossref_primary_10_7717_peerj_14200 crossref_primary_10_3389_fimmu_2025_1531191 crossref_primary_10_3389_fmed_2022_1071115 crossref_primary_10_1093_rheumatology_keaa673 crossref_primary_10_1093_rheumatology_keaa672 crossref_primary_10_1136_lupus_2020_000458 crossref_primary_10_1186_s13075_020_02276_y crossref_primary_10_3390_tropicalmed9100247 crossref_primary_10_1007_s00467_021_05363_7 crossref_primary_10_1136_lupus_2024_001264 crossref_primary_10_1016_j_jaut_2022_102900 crossref_primary_10_1016_j_ejr_2024_03_002 crossref_primary_10_3389_fimmu_2021_686501 crossref_primary_10_1007_s12016_021_08918_6 crossref_primary_10_3389_fmed_2025_1429337 crossref_primary_10_1002_iid3_1161 crossref_primary_10_1007_s12630_023_02506_2 crossref_primary_10_1111_1756_185X_15292 crossref_primary_10_1177_09612033221129776 crossref_primary_10_1093_rheumatology_keaa662 crossref_primary_10_1097_BOR_0000000000001042 crossref_primary_10_1051_jbio_2024005 |
| Cites_doi | 10.1056/NEJMra071297 10.1002/acr.22539 10.3899/jrheum.180478 10.1056/NEJMra1100359 10.1191/0961203304lu2020oa 10.1002/art.34473 10.1177/0961203318763732 10.1002/acr.22583 10.1002/art.1780251101 10.1002/art.23015 10.1177/0961203318776093 10.1021/acs.jproteome.8b00811 10.5301/jsrd.5000213 10.1002/acr.23503 10.1177/0961203316644338 10.1002/art.40674 10.1002/acr.23317 10.1002/acr.23292 10.1016/j.semarthrit.2010.12.001 10.1002/art.23018 10.1016/j.jclinepi.2013.12.009 10.1002/art.22003 10.1002/art.24699 10.1016/S0950-3579(05)80189-X 10.1136/annrheumdis-2018-214685 10.1002/acr.22484 10.1038/nrrheum.2013.103 10.7326/0003-4819-146-7-200704030-00004 |
| ContentType | Journal Article |
| Copyright | Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. 2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. |
| Copyright_xml | – notice: Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. – notice: 2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 88I 8AF 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI BTHHO CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9- K9. LK8 M0R M0S M1P M2P M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 ADTOC UNPAY |
| DOI | 10.1136/annrheumdis-2018-214819 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection BMJ Journals ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Biological Sciences Consumer Health Database ProQuest Health & Medical Collection Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic Unpaywall for CDI: Periodical Content Unpaywall |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Family Health (Alumni Edition) ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition BMJ Journals ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest Central Student ProQuest Central Student |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 4 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1468-2060 |
| EndPage | 1159 |
| ExternalDocumentID | 10.1136/annrheumdis-2018-214819 31383717 10_1136_annrheumdis_2018_214819 annrheumdis |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GrantInformation_xml | – fundername: American College of Rheumatology – fundername: European League Against Rheumatism funderid: http://dx.doi.org/10.13039/501100008741 – fundername: Department of Health grantid: CS-2013-13-032 – fundername: Medical Research Council grantid: MR/M01665X/1 – fundername: Department of Health grantid: RTF/01/097 – fundername: MRF_ grantid: MRF-159-0003-ELP-VITAL |
| GroupedDBID | --- .55 .GJ .VT 169 23M 2WC 39C 3O- 4.4 40O 53G 5GY 5RE 5VS 6J9 7X7 7~S 88E 88I 8AF 8FE 8FH 8FI 8FJ 8R4 8R5 AAHLL AAKAS AAOJX AAWJN AAWTL AAXUO ABAAH ABJNI ABKDF ABMQD ABOCM ABTFR ABUWG ABVAJ ACGFO ACGFS ACGOD ACGTL ACHTP ACMFJ ACOAB ACOFX ACPRK ACQSR ACTZY ADBBV ADCEG ADFRT ADUGQ ADZCM AEKJL AENEX AFKRA AFWFF AGQPQ AHMBA AHNKE AHQMW AJYBZ AKKEP ALIPV ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF AZFZN AZQEC BAWUL BBNVY BENPR BHPHI BKNYI BLJBA BOMFT BPHCQ BTFSW BTHHO BVXVI C1A C45 CAG CCPQU COF CS3 CXRWF DIK DWQXO E3Z EBS EJD F5P FDB FYUFA GNUQQ H13 HAJ HCIFZ HMCUK HYE HZ~ IAO IEA IHR INH INR IOF ITC J5H K9- KQ8 L7B LK8 M0R M1P M2P M7P N9A NTWIH NXWIF O9- OK1 OVD P2P PHGZT PQQKQ PROAC PSQYO Q2X R53 RHI RMJ RPM RV8 RWL RXW TAE TEORI TR2 UAW UKHRP UYXKK V24 VM9 VVN W2D W8F WH7 WOQ X6Y X7M YFH YOC YQY ZGI ZXP 0R~ AAFWJ AALRI AAYXX CITATION PHGZM PJZUB PPXIY PQGLB PUEGO CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK K9. PKEHL PQEST PQUKI PRINS Q9U 7X8 ADTOC UNPAY |
| ID | FETCH-LOGICAL-b505t-543d8cee42e5a900c95db26b6082282fb3f783802ec5d9b67093485ba05a93a33 |
| IEDL.DBID | 7X7 |
| ISSN | 0003-4967 1468-2060 |
| IngestDate | Wed Aug 20 00:20:09 EDT 2025 Wed Oct 01 17:13:58 EDT 2025 Fri Jul 25 11:00:12 EDT 2025 Fri Jul 25 11:04:05 EDT 2025 Mon Jul 21 05:42:00 EDT 2025 Wed Oct 01 02:40:42 EDT 2025 Thu Apr 24 23:11:22 EDT 2025 Fri Apr 25 03:24:12 EDT 2025 Thu Apr 24 22:50:54 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Keywords | systemic lupus erythematosus classification criteria consensus methods lupus multi-criteria decision analysis validation |
| Language | English |
| License | Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b505t-543d8cee42e5a900c95db26b6082282fb3f783802ec5d9b67093485ba05a93a33 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Literature Review-3 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0003-0548-4983 0000-0001-9475-1363 0000-0002-1555-9021 0000-0002-9074-0592 0000-0002-0807-7139 0000-0002-6478-7725 0000-0002-3250-3804 0000-0001-7788-1043 0000-0001-7506-9166 0000-0003-4471-8375 0000-0001-6988-6178 0000-0003-2238-0975 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://ard.bmj.com/content/annrheumdis/78/9/1151.full.pdf |
| PMID | 31383717 |
| PQID | 2272150532 |
| PQPubID | 2041045 |
| PageCount | 9 |
| ParticipantIDs | unpaywall_primary_10_1136_annrheumdis_2018_214819 proquest_miscellaneous_2268940013 proquest_journals_3104121114 proquest_journals_2272150532 pubmed_primary_31383717 crossref_citationtrail_10_1136_annrheumdis_2018_214819 crossref_primary_10_1136_annrheumdis_2018_214819 bmj_primary_10_1136_annrheumdis_2018_214819 bmj_journals_10_1136_annrheumdis_2018_214819 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20190900 2019-09-00 20190901 |
| PublicationDateYYYYMMDD | 2019-09-01 |
| PublicationDate_xml | – month: 9 year: 2019 text: 20190900 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Kidlington |
| PublicationTitle | Annals of the rheumatic diseases |
| PublicationTitleAbbrev | Ann Rheum Dis |
| PublicationTitleAlternate | Ann Rheum Dis |
| PublicationYear | 2019 |
| Publisher | BMJ Publishing Group Ltd and European League Against Rheumatism Elsevier Limited |
| Publisher_xml | – name: BMJ Publishing Group Ltd and European League Against Rheumatism – name: Elsevier Limited |
| References | Costenbader, Schur (R32) 2015; 67 Rahman, Isenberg (R2) 2008; 358 Costenbader, Karlson, Mandl (R15) 2002; 29 Inês, Silva, Galindo (R11) 2015; 67 Johnson, Khanna, Daikh (R26) 2019; 46 Wallace, Stohl, Furie (R28) 2009; 61 Hochberg (R7) 1725; 1997 Tan, Cohen, Fries (R6) 1982; 25 Tsokos (R3) 2011; 365 Johnson, Hinchcliff, Asano (R29) 2016; 1 Johnson, Goek, Singh-Grewal (R4) 2007; 57 Dougados, Gossec (R14) 2007; 57 Nair, Aggarwal, Khanna (R20) 2011; 41 Mosca, Costenbader, Johnson (R18) 2019; 71 Tedeschi, Johnson, Boumpas (R24) 2019; 78 Ganczarczyk, Urowitz, Gladman (R31) 1989; 16 Touma, Cervera, Brinks (R21) 2017; 69 Johnson, Naden, Fransen (R23) 2014; 67 Tedeschi, Johnson, Boumpas (R22) 2018; 70 Felson, Anderson (R12) 1995; 9 Leuchten, Hoyer, Brinks (R16) 2018; 70 Aggarwal, Ringold, Khanna (R5) 2015; 67 Aringer, Dörner, Leuchten (R10) 2016; 25 Leuchten, Milke, Winkler-Rohlfing (R19) 2018; 27 Littlejohn, Marder, Lewis (R30) 2018; 27 Albrecht, Berlin, Braverman (R8) 2004; 13 Bertsias, Pamfil, Fanouriakis (R1) 2013; 9 Singh, Solomon, Dougados (R13) 2006; 55 Schmajuk, Hoyer, Aringer (R17) 2018; 70 Hsieh, Everhart, Byrd-Holt (R33) 2007; 146 Petri, Orbai, Alarcón (R9) 2012; 64 Torell, Eketjäll, Idborg (R27) 2019; 18 Dougados, Gossec 2007; 57 Tedeschi, Johnson, Boumpas 2019; 78 Hsieh, Everhart, Byrd-Holt 2007; 146 Rahman, Isenberg 2008; 358 Bertsias, Pamfil, Fanouriakis 2013; 9 Tan, Cohen, Fries 1982; 25 Inês, Silva, Galindo 2015; 67 Johnson, Goek, Singh-Grewal 2007; 57 Nair, Aggarwal, Khanna 2011; 41 Tedeschi, Johnson, Boumpas 2018; 70 Johnson, Naden, Fransen 2014; 67 Ganczarczyk, Urowitz, Gladman 1989; 16 Costenbader, Karlson, Mandl 2002; 29 Tsokos 2011; 365 Aggarwal, Ringold, Khanna 2015; 67 Felson, Anderson 1995; 9 Wallace, Stohl, Furie 2009; 61 Mosca, Costenbader, Johnson 2019; 71 Schmajuk, Hoyer, Aringer 2018; 70 Hochberg 1725; 1997 Johnson, Khanna, Daikh 2019; 46 Torell, Eketjäll, Idborg 2019; 18 Petri, Orbai, Alarcón 2012; 64 Touma, Cervera, Brinks 2017; 69 Aringer, Dörner, Leuchten 2016; 25 Johnson, Hinchcliff, Asano 2016; 1 Costenbader, Schur 2015; 67 Albrecht, Berlin, Braverman 2004; 13 Singh, Solomon, Dougados 2006; 55 Leuchten, Hoyer, Brinks 2018; 70 Littlejohn, Marder, Lewis 2018; 27 Leuchten, Milke, Winkler-Rohlfing 2018; 27 Torell (10.1136/annrheumdis-2018-214819_bib27) 2019; 18 Leuchten (10.1136/annrheumdis-2018-214819_bib19) 2018; 27 Johnson (10.1136/annrheumdis-2018-214819_bib29) 2016; 1 Petri (10.1136/annrheumdis-2018-214819_bib9) 2012; 64 Dougados (10.1136/annrheumdis-2018-214819_bib14) 2007; 57 Schmajuk (10.1136/annrheumdis-2018-214819_bib17) 2018; 70 Wallace (10.1136/annrheumdis-2018-214819_bib28) 2009; 61 Inês (10.1136/annrheumdis-2018-214819_bib11) 2015; 67 Aringer (10.1136/annrheumdis-2018-214819_bib10) 2016; 25 Leuchten (10.1136/annrheumdis-2018-214819_bib16) 2018; 70 Touma (10.1136/annrheumdis-2018-214819_bib21) 2017; 69 Bertsias (10.1136/annrheumdis-2018-214819_bib1) 2013; 9 Johnson (10.1136/annrheumdis-2018-214819_bib23) 2014; 67 Hsieh (10.1136/annrheumdis-2018-214819_bib33) 2007; 146 Aggarwal (10.1136/annrheumdis-2018-214819_bib5) 2015; 67 Mosca (10.1136/annrheumdis-2018-214819_bib18) 2019; 71 Johnson (10.1136/annrheumdis-2018-214819_bib26) 2019; 46 Albrecht (10.1136/annrheumdis-2018-214819_bib8) 2004; 13 Costenbader (10.1136/annrheumdis-2018-214819_bib32) 2015; 67 Hochberg (10.1136/annrheumdis-2018-214819_bib7) 1725; 1997 Felson (10.1136/annrheumdis-2018-214819_bib12) 1995; 9 Ganczarczyk (10.1136/annrheumdis-2018-214819_bib31) 1989; 16 Johnson (10.1136/annrheumdis-2018-214819_bib4) 2007; 57 Tan (10.1136/annrheumdis-2018-214819_bib6) 1982; 25 Littlejohn (10.1136/annrheumdis-2018-214819_bib30) 2018; 27 Tedeschi (10.1136/annrheumdis-2018-214819_bib22) 2018; 70 Tedeschi (10.1136/annrheumdis-2018-214819_bib24) 2019; 78 Singh (10.1136/annrheumdis-2018-214819_bib13) 2006; 55 Nair (10.1136/annrheumdis-2018-214819_bib20) 2011; 41 Rahman (10.1136/annrheumdis-2018-214819_bib2) 2008; 358 Costenbader (10.1136/annrheumdis-2018-214819_bib15) 2002; 29 Tsokos (10.1136/annrheumdis-2018-214819_bib3) 2011; 365 Efron (10.1136/annrheumdis-2018-214819_bib25) 1994 32122908 - Ann Rheum Dis. 2022 Feb;81(2):e22. doi: 10.1136/annrheumdis-2020-217017. 31585929 - Ann Rheum Dis. 2021 Aug;80(8):e127. doi: 10.1136/annrheumdis-2019-216338. 31501139 - Ann Rheum Dis. 2021 Aug;80(8):e122. doi: 10.1136/annrheumdis-2019-216222. 31540932 - Ann Rheum Dis. 2021 Aug;80(8):e124. doi: 10.1136/annrheumdis-2019-216259. 31604707 - Ann Rheum Dis. 2021 Aug;80(8):e125. doi: 10.1136/annrheumdis-2019-216337. 31533932 - Ann Rheum Dis. 2021 Aug;80(8):e123. doi: 10.1136/annrheumdis-2019-216250. 31862701 - Ann Rheum Dis. 2021 Dec;80(12):e193. doi: 10.1136/annrheumdis-2019-216807. 32122907 - Ann Rheum Dis. 2022 Feb;81(2):e23. doi: 10.1136/annrheumdis-2020-217105. 31862703 - Ann Rheum Dis. 2021 Dec;80(12):e191. doi: 10.1136/annrheumdis-2019-216803. 31527019 - Ann Rheum Dis. 2021 Aug;80(8):e126. doi: 10.1136/annrheumdis-2019-216253. 31811057 - Ann Rheum Dis. 2021 Dec;80(12):e192. doi: 10.1136/annrheumdis-2019-216695. 31811058 - Ann Rheum Dis. 2021 Dec;80(12):e190. doi: 10.1136/annrheumdis-2019-216712. |
| References_xml | – volume: 358 start-page: 929 year: 2008 ident: R2 article-title: Systemic lupus erythematosus publication-title: N Engl J Med doi: 10.1056/NEJMra071297 – volume: 146 year: 2007 ident: R33 article-title: Prevalence of neutropenia in the US population: age, sex, smoking status, and ethnic differences publication-title: Ann Intern Med – volume: 67 start-page: 1180 year: 2015 ident: R11 article-title: Classification of systemic lupus erythematosus: systemic lupus international collaborating clinics versus American College of rheumatology criteria. A comparative study of 2,055 patients from a real-life, International systemic lupus erythematosus cohort publication-title: Arthritis Care Res doi: 10.1002/acr.22539 – volume: 46 start-page: 721 year: 2019 ident: R26 article-title: Use of consensus methodology to determine candidate items for systemic lupus erythematosus classification criteria publication-title: J Rheumatol doi: 10.3899/jrheum.180478 – volume: 365 start-page: 2110 year: 2011 ident: R3 article-title: Systemic lupus erythematosus publication-title: N Engl J Med doi: 10.1056/NEJMra1100359 – volume: 13 start-page: 839 year: 2004 ident: R8 article-title: Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus publication-title: Lupus doi: 10.1191/0961203304lu2020oa – volume: 64 start-page: 2677 year: 2012 ident: R9 article-title: Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/art.34473 – volume: 27 start-page: 1123 year: 2018 ident: R30 article-title: The ratio of erythrocyte sedimentation rate to C-reactive protein is useful in distinguishing infection from flare in systemic lupus erythematosus patients presenting with fever publication-title: Lupus doi: 10.1177/0961203318763732 – volume: 67 start-page: 891 year: 2015 ident: R5 article-title: Distinctions between diagnostic and classification criteria? publication-title: Arthritis Care Res doi: 10.1002/acr.22583 – volume: 25 start-page: 1271 year: 1982 ident: R6 article-title: The 1982 revised criteria for the classification of systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/art.1780251101 – volume: 16 start-page: 475 year: 1989 ident: R31 article-title: "Latent lupus". publication-title: J Rheumatol – volume: 57 start-page: 1112 year: 2007 ident: R14 article-title: Classification criteria for rheumatic diseases: why and how? publication-title: Arthritis Rheum doi: 10.1002/art.23015 – volume: 27 start-page: 1431 year: 2018 ident: R19 article-title: Early symptoms of systemic lupus erythematosus (SLE) recalled by 339 SLE patients publication-title: Lupus doi: 10.1177/0961203318776093 – volume: 18 start-page: 1208 year: 2019 ident: R27 article-title: Cytokine profiles in autoantibody defined subgroups of systemic lupus erythematosus publication-title: J Proteome Res doi: 10.1021/acs.jproteome.8b00811 – volume: 1 start-page: 277 year: 2016 ident: R29 article-title: Controversies: molecular vs. clinical systemic sclerosis classification publication-title: J Scleroderma Relat Disord doi: 10.5301/jsrd.5000213 – volume: 70 start-page: 1488 year: 2018 ident: R17 article-title: Multicenter Delphi exercise to identify important key items for classifying systemic lupus erythematosus publication-title: Arthritis Care Res doi: 10.1002/acr.23503 – volume: 25 start-page: 805 year: 2016 ident: R10 article-title: Toward new criteria for systemic lupus erythematosus-a standpoint publication-title: Lupus doi: 10.1177/0961203316644338 – volume: 71 start-page: 91 year: 2019 ident: R18 article-title: Brief report: how do patients with newly diagnosed systemic lupus erythematosus present? A multicenter cohort of early systemic lupus erythematosus to inform the development of new classification criteria publication-title: Arthritis Rheumatol doi: 10.1002/art.40674 – volume: 70 start-page: 571 year: 2018 ident: R22 article-title: Developing and refining new candidate criteria for systemic lupus erythematosus classification: an international collaboration publication-title: Arthritis Care Res doi: 10.1002/acr.23317 – volume: 70 start-page: 428 year: 2018 ident: R16 article-title: Performance of antinuclear antibodies for classifying systemic lupus erythematosus: a systematic literature review and meta-regression of diagnostic data publication-title: Arthritis Care Res doi: 10.1002/acr.23292 – volume: 41 start-page: 95 year: 2011 ident: R20 article-title: Methods of formal consensus in classification/diagnostic criteria and guideline development publication-title: Semin Arthritis Rheum doi: 10.1016/j.semarthrit.2010.12.001 – volume: 57 start-page: 1119 year: 2007 ident: R4 article-title: Classification criteria in rheumatic diseases: a review of methodologic properties publication-title: Arthritis Rheum doi: 10.1002/art.23018 – volume: 67 start-page: 706 year: 2014 ident: R23 article-title: Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2013.12.009 – volume: 1997 year: 1725 ident: R7 article-title: Updating the American College of rheumatology revised criteria for the classification of systemic lupus erythematosus publication-title: Arthritis Rheum – volume: 69 year: 2017 ident: R21 article-title: Associations among classification criteria items within systemic lupus erythematosus publication-title: Arthritis Rheumatol – volume: 29 start-page: 2545 year: 2002 ident: R15 article-title: Defining lupus cases for clinical studies: the Boston weighted criteria for the classification of systemic lupus erythematosus publication-title: J Rheumatol – volume: 55 start-page: 348 year: 2006 ident: R13 article-title: Development of classification and response criteria for rheumatic diseases publication-title: Arthritis Rheum doi: 10.1002/art.22003 – volume: 61 start-page: 1168 year: 2009 ident: R28 article-title: A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/art.24699 – volume: 9 start-page: 253 year: 1995 ident: R12 article-title: Methodological and statistical approaches to criteria development in rheumatic diseases publication-title: Baillière's Clinical Rheumatology doi: 10.1016/S0950-3579(05)80189-X – volume: 78 start-page: 634 year: 2019 ident: R24 article-title: Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2018-214685 – volume: 67 start-page: 593 year: 2015 ident: R32 article-title: We need better classification and terminology for "people at high risk of or in the process of developing lupus" publication-title: Arthritis Care Res doi: 10.1002/acr.22484 – volume: 9 start-page: 687 year: 2013 ident: R1 article-title: Diagnostic criteria for systemic lupus erythematosus: has the time come? publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2013.103 – volume: 67 start-page: 891 year: 2015 article-title: Distinctions between diagnostic and classification criteria? publication-title: Arthritis Care Res doi: 10.1002/acr.22583 – volume: 55 start-page: 348 year: 2006 article-title: Development of classification and response criteria for rheumatic diseases publication-title: Arthritis Rheum doi: 10.1002/art.22003 – volume: 69 year: 2017 article-title: Associations among classification criteria items within systemic lupus erythematosus publication-title: Arthritis Rheumatol – volume: 64 start-page: 2677 year: 2012 article-title: Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/art.34473 – volume: 67 start-page: 706 year: 2014 article-title: Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2013.12.009 – volume: 27 start-page: 1123 year: 2018 article-title: The ratio of erythrocyte sedimentation rate to C-reactive protein is useful in distinguishing infection from flare in systemic lupus erythematosus patients presenting with fever publication-title: Lupus doi: 10.1177/0961203318763732 – volume: 70 start-page: 571 year: 2018 article-title: Developing and refining new candidate criteria for systemic lupus erythematosus classification: an international collaboration publication-title: Arthritis Care Res doi: 10.1002/acr.23317 – volume: 25 start-page: 1271 year: 1982 article-title: The 1982 revised criteria for the classification of systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/art.1780251101 – volume: 70 start-page: 428 year: 2018 article-title: Performance of antinuclear antibodies for classifying systemic lupus erythematosus: a systematic literature review and meta-regression of diagnostic data publication-title: Arthritis Care Res doi: 10.1002/acr.23292 – volume: 67 start-page: 593 year: 2015 article-title: We need better classification and terminology for "people at high risk of or in the process of developing lupus" publication-title: Arthritis Care Res doi: 10.1002/acr.22484 – volume: 18 start-page: 1208 year: 2019 article-title: Cytokine profiles in autoantibody defined subgroups of systemic lupus erythematosus publication-title: J Proteome Res doi: 10.1021/acs.jproteome.8b00811 – volume: 146 year: 2007 article-title: Prevalence of neutropenia in the US population: age, sex, smoking status, and ethnic differences publication-title: Ann Intern Med – volume: 41 start-page: 95 year: 2011 article-title: Methods of formal consensus in classification/diagnostic criteria and guideline development publication-title: Semin Arthritis Rheum doi: 10.1016/j.semarthrit.2010.12.001 – volume: 16 start-page: 475 year: 1989 article-title: "Latent lupus". publication-title: J Rheumatol – volume: 71 start-page: 91 year: 2019 article-title: Brief report: how do patients with newly diagnosed systemic lupus erythematosus present? A multicenter cohort of early systemic lupus erythematosus to inform the development of new classification criteria publication-title: Arthritis Rheumatol doi: 10.1002/art.40674 – volume: 29 start-page: 2545 year: 2002 article-title: Defining lupus cases for clinical studies: the Boston weighted criteria for the classification of systemic lupus erythematosus publication-title: J Rheumatol – volume: 78 start-page: 634 year: 2019 article-title: Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2018-214685 – volume: 13 start-page: 839 year: 2004 article-title: Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus publication-title: Lupus doi: 10.1191/0961203304lu2020oa – volume: 57 start-page: 1112 year: 2007 article-title: Classification criteria for rheumatic diseases: why and how? publication-title: Arthritis Rheum doi: 10.1002/art.23015 – volume: 1997 year: 1725 article-title: Updating the American College of rheumatology revised criteria for the classification of systemic lupus erythematosus publication-title: Arthritis Rheum – volume: 9 start-page: 253 year: 1995 article-title: Methodological and statistical approaches to criteria development in rheumatic diseases publication-title: Baillière's Clinical Rheumatology doi: 10.1016/S0950-3579(05)80189-X – volume: 9 start-page: 687 year: 2013 article-title: Diagnostic criteria for systemic lupus erythematosus: has the time come? publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2013.103 – volume: 27 start-page: 1431 year: 2018 article-title: Early symptoms of systemic lupus erythematosus (SLE) recalled by 339 SLE patients publication-title: Lupus doi: 10.1177/0961203318776093 – volume: 57 start-page: 1119 year: 2007 article-title: Classification criteria in rheumatic diseases: a review of methodologic properties publication-title: Arthritis Rheum doi: 10.1002/art.23018 – volume: 46 start-page: 721 year: 2019 article-title: Use of consensus methodology to determine candidate items for systemic lupus erythematosus classification criteria publication-title: J Rheumatol doi: 10.3899/jrheum.180478 – volume: 1 start-page: 277 year: 2016 article-title: Controversies: molecular vs. clinical systemic sclerosis classification publication-title: J Scleroderma Relat Disord doi: 10.5301/jsrd.5000213 – volume: 61 start-page: 1168 year: 2009 article-title: A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/art.24699 – volume: 25 start-page: 805 year: 2016 article-title: Toward new criteria for systemic lupus erythematosus-a standpoint publication-title: Lupus doi: 10.1177/0961203316644338 – volume: 358 start-page: 929 year: 2008 article-title: Systemic lupus erythematosus publication-title: N Engl J Med doi: 10.1056/NEJMra071297 – volume: 365 start-page: 2110 year: 2011 article-title: Systemic lupus erythematosus publication-title: N Engl J Med doi: 10.1056/NEJMra1100359 – volume: 67 start-page: 1180 year: 2015 article-title: Classification of systemic lupus erythematosus: systemic lupus international collaborating clinics versus American College of rheumatology criteria. A comparative study of 2,055 patients from a real-life, International systemic lupus erythematosus cohort publication-title: Arthritis Care Res doi: 10.1002/acr.22539 – volume: 70 start-page: 1488 year: 2018 article-title: Multicenter Delphi exercise to identify important key items for classifying systemic lupus erythematosus publication-title: Arthritis Care Res doi: 10.1002/acr.23503 – volume: 67 start-page: 706 year: 2014 ident: 10.1136/annrheumdis-2018-214819_bib23 article-title: Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2013.12.009 – volume: 25 start-page: 1271 year: 1982 ident: 10.1136/annrheumdis-2018-214819_bib6 article-title: The 1982 revised criteria for the classification of systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/art.1780251101 – volume: 25 start-page: 805 year: 2016 ident: 10.1136/annrheumdis-2018-214819_bib10 article-title: Toward new criteria for systemic lupus erythematosus-a standpoint publication-title: Lupus doi: 10.1177/0961203316644338 – volume: 70 start-page: 428 year: 2018 ident: 10.1136/annrheumdis-2018-214819_bib16 article-title: Performance of antinuclear antibodies for classifying systemic lupus erythematosus: a systematic literature review and meta-regression of diagnostic data publication-title: Arthritis Care Res doi: 10.1002/acr.23292 – volume: 365 start-page: 2110 year: 2011 ident: 10.1136/annrheumdis-2018-214819_bib3 article-title: Systemic lupus erythematosus publication-title: N Engl J Med doi: 10.1056/NEJMra1100359 – volume: 9 start-page: 687 year: 2013 ident: 10.1136/annrheumdis-2018-214819_bib1 article-title: Diagnostic criteria for systemic lupus erythematosus: has the time come? publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2013.103 – volume: 70 start-page: 571 year: 2018 ident: 10.1136/annrheumdis-2018-214819_bib22 article-title: Developing and refining new candidate criteria for systemic lupus erythematosus classification: an international collaboration publication-title: Arthritis Care Res doi: 10.1002/acr.23317 – volume: 27 start-page: 1431 year: 2018 ident: 10.1136/annrheumdis-2018-214819_bib19 article-title: Early symptoms of systemic lupus erythematosus (SLE) recalled by 339 SLE patients publication-title: Lupus doi: 10.1177/0961203318776093 – volume: 57 start-page: 1119 year: 2007 ident: 10.1136/annrheumdis-2018-214819_bib4 article-title: Classification criteria in rheumatic diseases: a review of methodologic properties publication-title: Arthritis Rheum doi: 10.1002/art.23018 – volume: 9 start-page: 253 year: 1995 ident: 10.1136/annrheumdis-2018-214819_bib12 article-title: Methodological and statistical approaches to criteria development in rheumatic diseases publication-title: Baillière's Clinical Rheumatology doi: 10.1016/S0950-3579(05)80189-X – volume: 67 start-page: 891 year: 2015 ident: 10.1136/annrheumdis-2018-214819_bib5 article-title: Distinctions between diagnostic and classification criteria? publication-title: Arthritis Care Res doi: 10.1002/acr.22583 – volume: 16 start-page: 475 year: 1989 ident: 10.1136/annrheumdis-2018-214819_bib31 article-title: “Latent lupus”. publication-title: J Rheumatol – volume: 1 start-page: 277 year: 2016 ident: 10.1136/annrheumdis-2018-214819_bib29 article-title: Controversies: molecular vs. clinical systemic sclerosis classification publication-title: J Scleroderma Relat Disord doi: 10.5301/jsrd.5000213 – volume: 57 start-page: 1112 year: 2007 ident: 10.1136/annrheumdis-2018-214819_bib14 article-title: Classification criteria for rheumatic diseases: why and how? publication-title: Arthritis Rheum doi: 10.1002/art.23015 – volume: 29 start-page: 2545 year: 2002 ident: 10.1136/annrheumdis-2018-214819_bib15 article-title: Defining lupus cases for clinical studies: the Boston weighted criteria for the classification of systemic lupus erythematosus publication-title: J Rheumatol – volume: 41 start-page: 95 year: 2011 ident: 10.1136/annrheumdis-2018-214819_bib20 article-title: Methods of formal consensus in classification/diagnostic criteria and guideline development publication-title: Semin Arthritis Rheum doi: 10.1016/j.semarthrit.2010.12.001 – volume: 46 start-page: 721 year: 2019 ident: 10.1136/annrheumdis-2018-214819_bib26 article-title: Use of consensus methodology to determine candidate items for systemic lupus erythematosus classification criteria publication-title: J Rheumatol doi: 10.3899/jrheum.180478 – year: 1994 ident: 10.1136/annrheumdis-2018-214819_bib25 – volume: 64 start-page: 2677 year: 2012 ident: 10.1136/annrheumdis-2018-214819_bib9 article-title: Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/art.34473 – volume: 13 start-page: 839 year: 2004 ident: 10.1136/annrheumdis-2018-214819_bib8 article-title: Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus publication-title: Lupus doi: 10.1191/0961203304lu2020oa – volume: 69 year: 2017 ident: 10.1136/annrheumdis-2018-214819_bib21 article-title: Associations among classification criteria items within systemic lupus erythematosus publication-title: Arthritis Rheumatol – volume: 146 year: 2007 ident: 10.1136/annrheumdis-2018-214819_bib33 article-title: Prevalence of neutropenia in the US population: age, sex, smoking status, and ethnic differences publication-title: Ann Intern Med doi: 10.7326/0003-4819-146-7-200704030-00004 – volume: 27 start-page: 1123 year: 2018 ident: 10.1136/annrheumdis-2018-214819_bib30 article-title: The ratio of erythrocyte sedimentation rate to C-reactive protein is useful in distinguishing infection from flare in systemic lupus erythematosus patients presenting with fever publication-title: Lupus doi: 10.1177/0961203318763732 – volume: 70 start-page: 1488 year: 2018 ident: 10.1136/annrheumdis-2018-214819_bib17 article-title: Multicenter Delphi exercise to identify important key items for classifying systemic lupus erythematosus publication-title: Arthritis Care Res doi: 10.1002/acr.23503 – volume: 78 start-page: 634 year: 2019 ident: 10.1136/annrheumdis-2018-214819_bib24 article-title: Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2018-214685 – volume: 67 start-page: 1180 year: 2015 ident: 10.1136/annrheumdis-2018-214819_bib11 article-title: Classification of systemic lupus erythematosus: systemic lupus international collaborating clinics versus American College of rheumatology criteria. A comparative study of 2,055 patients from a real-life, International systemic lupus erythematosus cohort publication-title: Arthritis Care Res doi: 10.1002/acr.22539 – volume: 18 start-page: 1208 year: 2019 ident: 10.1136/annrheumdis-2018-214819_bib27 article-title: Cytokine profiles in autoantibody defined subgroups of systemic lupus erythematosus publication-title: J Proteome Res doi: 10.1021/acs.jproteome.8b00811 – volume: 61 start-page: 1168 year: 2009 ident: 10.1136/annrheumdis-2018-214819_bib28 article-title: A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/art.24699 – volume: 55 start-page: 348 year: 2006 ident: 10.1136/annrheumdis-2018-214819_bib13 article-title: Development of classification and response criteria for rheumatic diseases publication-title: Arthritis Rheum doi: 10.1002/art.22003 – volume: 71 start-page: 91 year: 2019 ident: 10.1136/annrheumdis-2018-214819_bib18 article-title: Brief report: how do patients with newly diagnosed systemic lupus erythematosus present? A multicenter cohort of early systemic lupus erythematosus to inform the development of new classification criteria publication-title: Arthritis Rheumatol doi: 10.1002/art.40674 – volume: 1997 year: 1725 ident: 10.1136/annrheumdis-2018-214819_bib7 article-title: Updating the American College of rheumatology revised criteria for the classification of systemic lupus erythematosus publication-title: Arthritis Rheum – volume: 67 start-page: 593 year: 2015 ident: 10.1136/annrheumdis-2018-214819_bib32 article-title: We need better classification and terminology for “people at high risk of or in the process of developing lupus” publication-title: Arthritis Care Res doi: 10.1002/acr.22484 – volume: 358 start-page: 929 year: 2008 ident: 10.1136/annrheumdis-2018-214819_bib2 article-title: Systemic lupus erythematosus publication-title: N Engl J Med doi: 10.1056/NEJMra071297 – reference: 31604707 - Ann Rheum Dis. 2021 Aug;80(8):e125. doi: 10.1136/annrheumdis-2019-216337. – reference: 31501139 - Ann Rheum Dis. 2021 Aug;80(8):e122. doi: 10.1136/annrheumdis-2019-216222. – reference: 32122907 - Ann Rheum Dis. 2022 Feb;81(2):e23. doi: 10.1136/annrheumdis-2020-217105. – reference: 32122908 - Ann Rheum Dis. 2022 Feb;81(2):e22. doi: 10.1136/annrheumdis-2020-217017. – reference: 31585929 - Ann Rheum Dis. 2021 Aug;80(8):e127. doi: 10.1136/annrheumdis-2019-216338. – reference: 31533932 - Ann Rheum Dis. 2021 Aug;80(8):e123. doi: 10.1136/annrheumdis-2019-216250. – reference: 31811058 - Ann Rheum Dis. 2021 Dec;80(12):e190. doi: 10.1136/annrheumdis-2019-216712. – reference: 31527019 - Ann Rheum Dis. 2021 Aug;80(8):e126. doi: 10.1136/annrheumdis-2019-216253. – reference: 31862701 - Ann Rheum Dis. 2021 Dec;80(12):e193. doi: 10.1136/annrheumdis-2019-216807. – reference: 31540932 - Ann Rheum Dis. 2021 Aug;80(8):e124. doi: 10.1136/annrheumdis-2019-216259. – reference: 31862703 - Ann Rheum Dis. 2021 Dec;80(12):e191. doi: 10.1136/annrheumdis-2019-216803. – reference: 31811057 - Ann Rheum Dis. 2021 Dec;80(12):e192. doi: 10.1136/annrheumdis-2019-216695. |
| SSID | ssj0000818 |
| Score | 2.719536 |
| SecondaryResourceType | review_article |
| Snippet | ObjectiveTo develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European League Against Rheumatism (EULAR) and... To develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European League Against Rheumatism (EULAR) and the... |
| SourceID | unpaywall proquest pubmed crossref bmj |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1151 |
| SubjectTerms | Antibodies Antinuclear antibodies Antiphospholipid antibodies Arthritis Classification classification criteria consensus methods Criteria Humans Immunoglobulins Immunology Literature reviews Lupus Lupus Erythematosus, Systemic - classification Medical research multi-criteria decision analysis Pathogenesis Patients Rheumatic Diseases Rheumatism Rheumatology Societies, Medical Systemic lupus erythematosus validation |
| SummonAdditionalLinks | – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELboVgL1wJsSVJCRuEGyTux44-MKUVWIVgixUhGHKH6Vhd3sapMIlRv_nJk8lvKQWvU8thPbk8znGc83hLzwWhiZahW2gUMhLQ-1ZVlowJZrD_bHtKQ-xyfyaCbenqan_a1KzIWBZYn08muXzYD8TGWNBVk2X1yztPNqPMnGagwoJo7QPR2trd8huxKDSyOyOzt5P_00lMgTqi0f26YWJUyy_nJXzOXFAUEUgxwOBci1swOP_tNA_YM698itplwX59-LxeKCJTq8Qz4Pc-guoHyLmlpH5sdf9I7Xm-RdcrsHqHTaadQ9csOV98nN4z4E_4D8hKkoOjjx6TtXnDWOTs-KOQBN-gEHx4SJ5XiIBdHeN0FXfhC3rnxqELjjTaVWOSj8vpA3uqAAo2lHMD03dNGsm4q6zXnHLruqmuohmR2--fj6KOzrOIQa8FUdpoLbDIyxSFxaKMaMSq1OpJbINp8lXnM_yXjGEmdSqzQyynGRpbpg0JwXnD8io3JVuseEammVTTzgKGXFxDPNZWy4SVIvjYfOAXkFC5v332GVt0cc3qZdD6ub447n3Y4H5CU2X3fEHpe3loNm5KZnUMdCHovLO7Jtxys_62BQvd-zSRI4r6dYy-O_YkDqAhn7YhGQ51sx_C4wBlSUbtXgEDJTAoF_QPY7jd6-Eo_RXRFPAhJvVfyq7_vkGn0OyKjeNO4poLpaP-s_318Fe01x priority: 102 providerName: Unpaywall |
| Title | 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus |
| URI | https://ard.bmj.com/content/78/9/1151.full https://www.ncbi.nlm.nih.gov/pubmed/31383717 https://www.proquest.com/docview/2272150532 https://www.proquest.com/docview/3104121114 https://www.proquest.com/docview/2268940013 https://ard.bmj.com/content/annrheumdis/78/9/1151.full.pdf |
| UnpaywallVersion | publishedVersion |
| Volume | 78 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1468-2060 dateEnd: 20241231 omitProxy: true ssIdentifier: ssj0000818 issn: 1468-2060 databaseCode: 7X7 dateStart: 19390101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1468-2060 dateEnd: 20241231 omitProxy: true ssIdentifier: ssj0000818 issn: 1468-2060 databaseCode: BENPR dateStart: 19390101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZoK_E4IN4ESmUkbhA1jh9JTmhBrSpEV1XFSsspih9pF-0my2Yj1CP_nJnE2QWBaE852E4cz9jzecb-hpA3pRZGSZ2FXeBQKMtDbaM0NGDLdQn2x3SkPqdjdTIRn6Zy6h1ujT9WOayJ3UJta4M-8sM4hr2KxDwG75ffQ8wahdFVn0Jjh-wxgCqo1ck02a7EKUuHjHkiU4k_38V4l-RldenahZ01oCgMtAX2BUi3s6MX3_60UX8Bz3vkTlsti6sfxXz-mzE6fkDuexRJR73YH5JbrnpEbp_6OPlj8hM-ltHB004_u-KidXR0UcwADdJz7BLealgcDgEb6h0ItC6H4s7fTg2iazxO1EmQwhqD5M4FBaxLexbomaHzdtk21K2uegrYummbJ2RyfPTl40noky2EGkZ1HUrBbQoWU8ROFlkUmUxaHSutkBI-jUvNyyTlaRQ7I22mkfaNi1TqIoLqvOD8Kdmt6so9J1Qrm9m4BLCTWZGUkeaKGW5iWSpTQuOAvINBzv1kafJuH8K7u9GDTHKUSd7LJCBvsfqyZ9-4vrYaZJcbT3OO2Tbm1zeMNg1v_K39QTm2f7NV1H8WA5wWSKvHREBeb4phTmOgpqhc3eIrVIoJ6xkPyLNe5zZd4gx9CiwJCNso4U37--L__X1J7qJ29ifo9snuetW6VwC51vqgm1cHZO_D0fjsHJ6T8dno6y_bjSw4 |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFLfGkBgcEF9jhQFGghNES2zHSQ4ITcDUsXYHtEm9hfgjo6hNuqbR1CP_EH8j7yVxCwKxXXa2nTh5z-_bv0fIq1wJLUOVeE3iUEjDPWX82NOgy1UO-kc3oD7DY9k_FZ9H4WiD_HR3YbCs0snERlCbUmOMfI8x8FVC7GPwfnbuYdcozK66FhotWxzZ5QW4bNW7w49A39eMHXw6-dD3uq4CnoLlCy8U3MSgGgSzYZb4vk5Co5hUErHPY5Yrnkcxj31mdWgShfhmXMShynyYzjMMgILIvym4LxCrPxpFa8kfB7Hr0CcSGXX1ZAFvmsrMv9l6asYVMGYA3Al-CML73FDT73_qxL8M3Ttkqy5m2fIim0x-U34H98jdzmql-y2b3ScbtnhAbg27vPxD8gNellAX2acDm53Vlu6fZWOwPukX3BLeopjuuQQR7QIWtMzdcBPfpxqteSxfajiGgkxDMOmMgm1NW9TpsaaTelZX1M6XLeRsWdXVI3J6LWTYJptFWdgdQpU0iWE5GFeJEVHuKy4DzTULc6lzWNwjb-Enp93hrNLG7-HNXWxHkxRpkrY06ZE3OH3Won1cPls62qW6g1XH7h6Tyxf6q4VXfteuY47116wPxj-HwXwXCOMXiB55uRoGGYKJoaywZY2PkHEi0Bvokcctz622xAOMYQRRjwQrJrzqfp_8f78vyFb_ZDhIB4fHR0_JbeTUtnpvl2wu5rV9BubeQj1vzhglX6_7UP8C9exkcA |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkQocEG8CBYwEJ4g2iR0nOSBUUVYtfQghKu0txK-yaDdZNhtVe-Rv8euYSeJdEIj20rPtxMk8PTP-hpAXVnIlYpn5beKQC818qYPUV2DLpQX7o1pQn6NjsXfCP4zi0Qb56e7CYFml04mtotaVwhj5IIrgrBJjH4OB7csiPu4O386--9hBCjOtrp1GxyIHZnkGx7f6zf4u0PplFA3ff3635_cdBnwJj1r4MWc6BTPBIxMXWRCoLNYyElIgDnoaWclskrI0iIyKdSYR64zxNJZFANNZgcFQUP9XE8YZlpMlo2RtBdIwdd36eCaSvrYsZG2DmflX00z1uAYmDYFT4UyCUD9X5PTbn_bxL6f3BrnWlLNieVZMJr8ZwuEtcrP3YOlOx3K3yYYp75Ctoz5Hf5f8gJdl1EX56aEpThtDd06LMXii9BNuCW9UTAcuWUT74AWtrBtuY_1UoWePpUwt91DQbwgsXVDws2mHQD1WdNLMmpqa-bKDn63qpr5HTi6FDPfJZlmV5iGhUuhMRxYcrUzzxAaSiVAxFcVWKAuLPfIafnLeC2qdt2cg1t7LdjTJkSZ5RxOPvMLpsw754_zZwtEuVz3EOnb6mJy_MFgtvPC7th1zrL9mLST_HAZXniOkX8g98nw1DPoEk0RFaaoGHyHSjOPJwCMPOp5bbYmFGM8IE4-EKya86H4f_X-_z8gWiHN-uH988JhcR0btCvm2yeZi3pgn4Pkt5NNWxCj5ctky_QvTR2ir |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELboVgL1wJsSVJCRuEGyTux44-MKUVWIVgixUhGHKH6Vhd3sapMIlRv_nJk8lvKQWvU8thPbk8znGc83hLzwWhiZahW2gUMhLQ-1ZVlowJZrD_bHtKQ-xyfyaCbenqan_a1KzIWBZYn08muXzYD8TGWNBVk2X1yztPNqPMnGagwoJo7QPR2trd8huxKDSyOyOzt5P_00lMgTqi0f26YWJUyy_nJXzOXFAUEUgxwOBci1swOP_tNA_YM698itplwX59-LxeKCJTq8Qz4Pc-guoHyLmlpH5sdf9I7Xm-RdcrsHqHTaadQ9csOV98nN4z4E_4D8hKkoOjjx6TtXnDWOTs-KOQBN-gEHx4SJ5XiIBdHeN0FXfhC3rnxqELjjTaVWOSj8vpA3uqAAo2lHMD03dNGsm4q6zXnHLruqmuohmR2--fj6KOzrOIQa8FUdpoLbDIyxSFxaKMaMSq1OpJbINp8lXnM_yXjGEmdSqzQyynGRpbpg0JwXnD8io3JVuseEammVTTzgKGXFxDPNZWy4SVIvjYfOAXkFC5v332GVt0cc3qZdD6ub447n3Y4H5CU2X3fEHpe3loNm5KZnUMdCHovLO7Jtxys_62BQvd-zSRI4r6dYy-O_YkDqAhn7YhGQ51sx_C4wBlSUbtXgEDJTAoF_QPY7jd6-Eo_RXRFPAhJvVfyq7_vkGn0OyKjeNO4poLpaP-s_318Fe01x |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=2019+European+League+Against+Rheumatism%2FAmerican+College+of+Rheumatology+classification+criteria+for+systemic+lupus+erythematosus&rft.jtitle=Annals+of+the+rheumatic+diseases&rft.au=Aringer%2C+Martin&rft.au=Costenbader%2C+Karen&rft.au=Daikh%2C+David&rft.au=Brinks%2C+Ralph&rft.date=2019-09-01&rft.pub=Elsevier+Limited&rft.issn=0003-4967&rft.eissn=1468-2060&rft.volume=78&rft.issue=9&rft.spage=1151&rft_id=info:doi/10.1136%2Fannrheumdis-2018-214819&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0003-4967&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0003-4967&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0003-4967&client=summon |